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Fertility intentions and contraceptive use are often not assessed in the context of HIV 
clinical care, representing a possible gap in many current programs if women’s family planning 
needs change over time. Additionally, women who are planning to conceive have different 
clinical needs than those what wish to prevent pregnancy, precipitating potential differences in 
the frequency with which women attend HIV clinical care visits. We used data from a 
prospective cohort study of 850 non-pregnant, HIV-infected women aged 18-35 on or initiating 
antiretroviral therapy (ART) in Johannesburg, South Africa between 2009 and 2010. In Aim 1, 
we used group-based trajectory modeling to identify distinct patterns of unmet need over the 12-
month study period. Half of the enrolled women were predicted to have a consistently high 
probability of unmet need, 22.9% a consistently low probability, 16.7% a decreasing probability, 
and 10.4% an increasing probability over time. In Aim 2, we estimated the effect of fertility 
intentions on attendance at HIV clinical care visits.  Women were classified as having either 
current fertility intentions (trying to conceive at time of interview), short-term fertility intentions 
(planning to conceive in the next 12 months), long-term fertility intentions (planning to conceive 
in the future) or having no plans to conceive. Attendance was assessed dichotomously (any 
attendance vs. none) in 90-day intervals. We used generalized estimating equations to estimate 
the effect of fertility intentions on the odds of attending clinic visits over the 12-month study 
period. We found no difference in clinic attendance by fertility intentions in the full cohort. 
 
iv 
Among women who had recently initiated ART, those that planned to conceive were more likely 
to attend HIV clinical care visits (aOR 2.95, 95% CI: 1.19, 7.30) than those with no plans to 
conceive. Through this research we have demonstrated that family planning needs can change 
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CHAPTER I: SPECIFIC AIMS
 
 
With expanded access to affordable antiretroviral therapy (ART) in sub-Saharan Africa 
and the recommendation of earlier thresholds for treatment initiation,1 HIV-infected women on 
ART are living longer healthier lives.2 For HIV-infected women on ART, using reliable methods 
of contraception to plan pregnancy when CD4 count is high and viral load is low benefits 
maternal health and contributes to the prevention of mother-to-child HIV transmission 
(PMTCT).3-5 However, despite growing recognition for greater integration of sexual and 
reproductive health services with HIV prevention, care, and treatment services,6 HIV-infected 
women still face difficulties meeting their contraceptive needs.7,8 
In South Africa, high incidence of unplanned pregnancy among women taking ART 
warrants a better and more nuanced understanding of the long-term changes in unmet 
contraceptive need that occur in the period following ART initiation.5 Identification of temporal 
trends in unmet need for contraception amidst ART scale-up could characterize novel 
opportunities to increase contraceptive use and strengthen integrated family planning and HIV 
programs.  
Successful expansion and implementation of ART also depends on maximizing the 
proportion of HIV-infected women who are engaged in HIV care.9 Loss to follow-up and low 
levels of ART adherence impede efforts to optimize treatment outcomes in HIV-infected 
patients.10 Myriad physical and psychosocial barriers to engagement in care have been 
identified among HIV-infected women,9,11-26 including pregnancy status.26-29 Pregnancy is 
associated with sub-optimal engagement in care among women who initiate ART through 
PMTCT;26,27 however rates of retention are markedly higher among women who initiate ART for 
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their own health.28,29 Health-seeking behaviors in HIV-infected women are in part motivated by 
maternal concerns regarding fetal health,9,11,24,28,30 and the desire to have an HIV-negative child 
may motivate women to remain engaged in care. Similarly, women trying to become pregnant 
may be motivated by horizontal transmission concerns to have a more consistent relationship 
with HIV care than women who are not trying to conceive. However, the relationship between 
fertility intentions and retention in care is not well understood. 
In this study, we leveraged a unique, observational cohort of HIV-infected women taking 
ART in South Africa to better characterize patterns of unmet need for contraception and the 
relationship between fertility intentions and engagement in HIV care. Data were prospectively 
collected from 850 women at repeat study visits over a one-year period at two ART initiation 
sites and two ART down-referral sites in Johannesburg. The specific aims of this study were to 
1) Describe longitudinal changes in unmet need for contraception following ART initiation and 2) 
Estimate the causal effect of fertility intentions on attendance at HIV clinical care visits.  
To address aim 1, we used group-based trajectory modeling to characterize changes in 
unmet need for contraception and identify factors that both predict and alter the developmental 
course of the outcome over the study period.31 To address aim 2, generalized linear models fit 
using generalized estimating equations (GEE) were used to compare the odds of attending 
clinic visits among women trying and not trying to conceive.  
Data from this cohort are well published,5,32,33 and indicate high rates of unplanned 
pregnancy among HIV-infected women after ART initiation.5 This study expands on these initial 
findings by 1) providing a nuanced and previously unexplored long-term assessment of unmet 
need for contraception and 2) evaluating the causal relationship of fertility intentions with 
attendance at HIV clinical care visits. Through this research, we have identified potential 
opportunities for integrated contraceptive and HIV counseling that may ultimately improve 






An estimated 25 million people are living with HIV in sub-Saharan Africa, accounting for 
more than 70% of all HIV infections worldwide.34 In South Africa, the majority of people living 
with HIV are women of reproductive age,34 and prevalence of HIV among young women is as 
much as three times that among young men.28,35 South Africa also has one of the largest 
national treatment programs in the world, accounting for 20% of all persons on antiretroviral 
therapy (ART) globally.36 
1. Aim 1. Longitudinal Patterns of Unmet Need for Contraception 
Widespread availability of antiretroviral therapy (ART) – together with expanded 
programs to promote access to reliable contraception and safer conception methods – have 
shifted the landscape of reproductive decision-making in sub-Saharan Africa.1,2,37-39 In South 
Africa, national service delivery guidelines promote the integration of sexual and reproductive 
health services with HIV prevention, care and treatment services to strengthen both family 
planning and HIV-related outcomes.40 However, implementation of these guidelines in clinical 
practice has been limited.41  
Comprehensive programs to reduce unmet need for contraception in HIV-infected 
women43 primarily focus on:  1) improving availability of services, 2) increasing 
education and information dissemination around contraceptive use and 3) improving 
contraceptive counseling at the provider level.8,44-47 However, even in settings where these 
enhanced family planning services are integrated with HIV clinical care visits, heath-facility 
factors such as high patient volume and a limited number of providers can affect patient-
provider interaction time and quality of care.48,49 Furthermore, negative attitudes towards 
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childbearing and concerns about mother-to-child transmission may preclude providers from 
routinely assessing fertility preferences and contraceptive use.50,51 Consequently, changes in 
the family planning needs of HIV-infected women may go undetected.  
Despite growing recognition for greater integration of sexual and reproductive 
health services with HIV prevention, care, and treatment services,6 HIV-infected women 
still face difficulties meeting their contraceptive needs.5,7,8,42  Updated guidelines from the 
World Health Organization (WHO) define population-level unmet need for family planning 
(“unmet need”) as the percentage of “married or in-union women of reproductive age who want 
to stop or postpone childbearing but who report that they are not using any method of 
contraception to prevent pregnancy”.52 Unmet need for family planning comprises two groups of 
women: 1) women with an unmet need for limiting, and 2) women with an unmet need for 
spacing. Women with an unmet need for limiting are those who desire no additional children and 
who do not currently use a reliable contraceptive method. Women with an unmet need for 
spacing are those who desire to postpone their next birth by a specified length of time and who 
do not currently use a reliable contraceptive method. Persistent barriers to family planning 
include lack of female decision-making power,53 poor economic resources,54 low quality care at 
family planning services,55 and desire for large families.56,57 
Family planning needs among HIV-infected women may differ from those of HIV-
uninfected women, particularly in the period following ART initiation. In some cross-
sectional studies, fertility intentions and desires have been shown to decrease following the 
initial diagnosis of HIV58,59 and rebound in the period following ART initiation.60-62 However, one 
longitudinal study in Uganda found that pregnancy desires and hormonal contraception use 
were not associated with time-on-ART.63 Still, unmet need for contraception may increase after 
ART initiation among women whom, after experiencing sub-fertility related to HIV-associated 
disease progression,64 fail to realize they are able conceive.65,66 We conceptualize fertility in 
HIV-infected women as a complex interplay of biological and behavioral processes that evolve 
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over the reproductive lifespan (Figure 2.1). At a provider level, careful and routine consideration 
of these factors may increase the capacity of HIV-infected women to prevent or delay 
pregnancy until they are clinically stable and virally suppressed, which is largely important for 
both maternal wellbeing and prevention of mother-to-child transmission (PMTCT).67-72 
For HIV-infected women taking ART, using reliable methods of contraception to 
plan pregnancy when CD4 count is high and viral load is low benefits maternal health 
and contributes to the prevention of mother-to-child HIV transmission (PMTCT).3-5 
Prevention of unplanned pregnancy through reliable contraceptive methods improves women’s 
health and reduces both maternal and infant mortality.71,72 Prevention of unplanned pregnancy 
is also an effective strategy to reduce mother-to-child transmission (MTCT) by preventing HIV-
infected births,73 and is the second prong of WHO’s four-pronged framework for PMTCT.74 
Indeed, several modeling studies have demonstrated that PMTCT prophylaxis is most effective 
when implemented in combination with programs to decrease unmet contraceptive need.73,75 
Decreasing the number of infants born to HIV-infected mothers by meeting their contraceptive 
needs could shift resources to provide more comprehensive monitoring of HIV treatment 
outcomes among women and children. 
Understanding patterns of unmet contraceptive need in HIV-infected women could 
potentially help providers better identify those who may be at risk for unintended 
pregnancy. Characterization of temporal trends or predictors of unmet need for contraception 
could inform more targeted screening practices that are better designed to identify women who 
will benefit from family planning interventions. In this investigation, we assessed distinct 
longitudinal patterns of unmet need for contraception over a 12-month period within a cohort of 
HIV-infected women taking ART in South Africa. 
2. Aim 2. Fertility Intentions and Attendance at HIV Clinical Care Visits 
ART  has been available in South Africa to those who are pregnant or breastfeeding 
since early 2015,76 but challenges persist keeping women engaged in care during pregnancy 
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and the postpartum period. ART coverage is significantly higher in HIV-infected women than in 
men in South Africa,36 but significant concerns around adherence and retention have emerged 
around women who obtain treatment during pregnancy.77-79 Several studies have reported sub-
optimal adherence and high incidence of loss to follow-up (LTFU) among women who initiate 
ART during pregnancy compared to women who initiate ART for their own health,26,27,29 
especially in the postpartum period.28,80,81 While factors that cause women to ultimately 
disengage from HIV care are complex and dynamic,77 some have hypothesized that women 
who initiate ART through PMTCT are ultimately less motivated to remain in care in the 
postpartum period after the risk of mother-to-child transmission has subsided.24,28,82 Declining 
adherence in the postpartum period has also been associated with lifestyle stressors and 
postpartum depression.28,83-86 Psychosocial barriers to adherence have also been identified, 
including concerns around disclosure and stigma, alcohol or drug use and drug regimen 
frequency or pill burden.18,19,26 However, the relationship between these determinants  of care 
attendance are poorly understood, and the extent to which childbearing decisions impact 
engagement in care- both in the preconception and postpartum periods- has not been well 
characterized.  
Successful expansion of ART in South Africa- including improved HIV outcomes- 
will depend on maximizing the proportion of those with HIV who consistently attend their 
routine clinical care visits and adhere to treatment in the period following diagnosis.9 
Suboptimal retention and low levels of ART adherence impede efforts to optimize treatment 
outcomes in HIV-infected women.10 Patients who disengage from care and interrupt treatment 
are also more likely to have an increased risk of drug resistance, morbidity and mortality.11,38,87 
Rates of loss to follow-up in resource limited settings are consistently high; among patients not 
yet on ART attrition occurs from the time of testing to completion of CD4 staging,88,89 from 
completing staging to repeat CD4 testing for ART eligibility,90,91 and from ART eligibility to ART 
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initiation.90,92,93 For patients who do initiate ART, a high risk of attrition occurs within the first 
year of treatment.94-96 
Women who are planning to conceive have different clinical needs than those who 
wish to prevent pregnancy, precipitating potential differences in the frequency with 
which women attend HIV clinical care visits. Concerns about horizontal transmission in the 
preconception period or PMTCT after conception may also motivate women who are planning to 
conceive to have a more consistent relationship with HIV care. Evidence distinguishing different 
HIV care patterns among women trying and not trying to conceive could potentially inform new 
models for care delivery the preconception period. Furthermore, an association between fertility 
intentions and HIV care attendance in the preconception period could potentially explain 
differences in care attendance during pregnancy and in the postpartum period.  Here, we 
estimated the effect of fertility intentions on attendance at HIV clinical care visits among HIV-




3. Tables and Figures 
 
 
FIGURE 2.1 Conceptual framework for the potential impact of antiretroviral therapy (ART) 
on fertility among HIV-infected women in sub-Saharan Africa.  
 
 
























CHAPTER III: RESEARCH DESIGN AND METHODS
 
1. Description of Data 
1.1 Data Source  
This study is a secondary, longitudinal analysis of data collected though a CDC-funded 
prospective cohort study.5,32,33 The goals of the original study (“Pregnancy Intentions and 
Incidence in HIV Positive Women on Antiretroviral Therapy in South Africa”) were to: 1) 
determine the incidence of pregnancy and 2) assess contraceptive use and associations with 
unplanned pregnancy in HIV-infected women enrolled on ART in Johannesburg, South Africa 
(Table 3.1). ART is provided free of charge by the Ministry of Health in South Africa based on 
pregnancy, immunological or clinical status. In early 2016 South Africa announced expanded 
ART access through universal “test and treat” (UTT) following World Health Organization 
(WHO) recommendations to initiate ART after HIV diagnosis regardless of disease severity or 
maternal immunological status.1 At the time of study enrollment, however, non-pregnant women 
were eligible for lifelong ART initiation only if they had a CD4 count ≤200 cells/ml or WHO 
clinical stage 4 diagnosis. 
1.2 Recruitment 
Enrollment occurred from August 2009 to January 2010 at four government-run ART 
outpatient clinics in inner city Johannesburg. Clinics included two ART initiation sites and two 
ART maintenance sites where patients continue treatment once they are clinically stable and 
responsive to ART. In practice, some patients attending ART initiation sites were previously 
initiated onto ART and had not been referred to a maintenance site due to patient reluctance to 
changing facilities, oversight on the clinic’s part or potential complications or risks that may 
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require physician attendance. Both clinic types were included to enroll patients with a diverse 
group of ART experiences.  
Patients were recruited by convenience sample at each of the four study sites over a two 
to three-month period, depending on when enrollment targets were met. Enrollment targets 
were site-specific and proportional to clinic size. All women who appeared ≤50 years of age who 
visited one of the four clinics during the enrollment period were approached and invited by 
research assistants to participate in a study related to reproductive health and experiences with 
ART. Interested individuals were provided additional information and underwent further 
screening. Those meeting eligibility criteria were informed of additional study details and 
consented to participate (Table 3.1). Consented patients were tested for pregnancy and those 
who were not pregnant were enrolled in the study. 
At the time of study enrollment, approximately 9,000 patients were receiving care at the 
two ART initiation sites and two ART maintenance sites. Roughly 3,000 (33.3%) of these 
patients were women who met the study’s eligibility criteria. A total of 850 women were targeted 
for enrollment into the study.  
1.3 Study Enrollment and Follow-Up 
A total of 850 non-pregnant women with a confirmed HIV diagnosis who were previously 
on or being initiated onto ART were recruited by convenience sample during routine clinic visits 
at four government-run ART outpatient clinics in inner city Johannesburg. Women completed an 
interviewer-administered questionnaire at enrollment (Baseline). Follow-up visits occurred every 
1-3 months based on clinic protocol and provincial ART supply, and the median time between 
visits was 1.8 months [interquartile range (IQR) 1–2]. Participants had a median of six post-
enrollment follow-up visits and contributed a median of 12 months [IQR 9–13] of follow-up to the 
cohort.  
Women who did not become pregnant during the study period were followed through the 
first clinical visit after completing 12 months of follow-up. Women who became pregnant during 
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the study period were followed through the entirety of their pregnancy, and thus may have 
contributed greater than 12 months of follow-up. 
1.4 Data Collection 
Baseline Questionnaire 
 Interviewer-administered questionnaires were conducted at Baseline in English, Zulu or 
Sotho to obtain behavioral study data. Questions were asked in the following seven domains: 
1. Demographics 
2. Health status and fertility history 
3. Fertility potential and intentions 
4. Sexual behavior and contraception use 
5. Fertility desires 
6. Perceptions of providers’ attitudes towards fertility 
7. Relationship dynamics 
Follow-Up Questionnaire 
 Contraceptive use and current fertility intentions were assessed at each follow-up visit via 
a short interviewer-administered tool in English, Zulu or Sotho. Questions were selected from a 
comprehensive review of the available literature and piloted prior to enrollment. 
Clinical Variables 
 Pregnancy testing was conducted at Baseline and during each follow-up visit. Pregnancy 
was determined using urine-based tests administered by study staff (One Step hCG Urine 
Pregnancy Test (UPT), Atlas Link Technology, Beijing) and positive UPTs were confirmed 
through repeat testing. ART regimen information, CD4 cell count and viral load data were 
collected at Baseline and during follow-up and confirmed through medical record review by the 
project coordinator and research assistants; pharmacy and laboratory records were used to 




2. Approach for Aim 1 
2.1 Overview 
We used group-based trajectory models to summarize longitudinal patterns of unmet 
need for contraception over the 12-month period. To identify factors associated with the 
developmental course of the outcome, we assigned women to trajectory groups using a 
maximum probability assignment rule and estimated predicted probabilities of trajectory group 
membership for individual-level characteristics measured at study entry. To assess model fit 
and to choose among the estimated trajectory models, we compared Bayesian Information 
Criterion (BIC) using Jeffreys’s scale of evidence for Bayes factors. 
2.2 Study Design 
This is a secondary analysis of a previously conducted prospective cohort study, 
“Pregnancy Intentions and Incidence in HIV Positive Women on Antiretroviral Therapy in South 
Africa. All analyses were conducted among the 850 HIV-infected women who were previously 
on or being initiated onto ART during study enrollment. We defined the study origin as the date 
of original study enrollment, and baseline characteristics were assessed via interviewer-
administered questionnaire. Follow-up began following study entry and concluded at the 
completion of 12 months. The primary outcome for Aim 1, unmet need for contraception, was 
assessed in monthly intervals beginning at enrollment and ending after the completion of 12 
months of follow-up via 1) a short interviewer-administered questionnaire (behavioral variables) 
and 2) through linked clinical, laboratory and pharmacy records (clinical variables). We selected 
monthly intervals to minimize missing data (longer intervals, fewer measurements) while also 
minimizing the occurrence of conflicting, individual measurement within a given interval (shorter 
intervals, greater measurements).  
2.3 Study Population 
The study population included all 850 HIV-infected women who were previously on or 
being initiated onto ART originally enrolled in the parent study. Women were eligible at study 
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enrollment if they: were older than 18 but less than 35 years of age, not pregnant or 
breastfeeding, had not delivered a pregnancy in the previous three months, were taking ART, 
were sexually active within the past 12 months, had previously undergone a tubal ligation, 
hysterectomy, bi-lateral oophorectomy or were diagnosed as permanently infertile (Table 3.1).  
2.4 Outcome Measures 
The primary outcome for Aim 1 is unmet need for contraception, measured at repeat 
visits over 12 months of study follow-up. Our interest lies in assessing unmet need for safe and 
highly effective reliable contraception among HIV-infected women on ART in South Africa. To 
determine unmet need for contraception in our study, we adapted the unmet need for family 
planning algorithm proposed by Bradley et al. (2012) (Figure 3.1).68 The algorithm was 
constructed to estimate unmet need for family planning using Demographic and Health Surveys 
(DHS) data, and accounts for multiple factors including fertility desires, contraceptive use, 
pregnancy status, fecundity and marital status. In our study, women were considered to have 
unmet need for contraception at a given study visit if they reported 1) being married, living with a 
partner, or being sexually active in the three months preceding study enrollment, 2) not currently 
trying to become pregnant, and 3) not reporting use of a reliable contraceptive method including 
oral contraceptives, injectables, a hormonal implant or an intrauterine device (Figure 3.2) As 
rates of unintended pregnancy are comparable among women who do not use family planning 
methods and among those who report condom use alone,5,65 women who reported condom use 
as their primary method of family planning were not considered to be using a reliable method of 
contraception. 
As a secondary outcome, we also assessed fertility intentions and contraceptive use 
measured at repeat visits over 12 months of study follow-up. 
Measuring unmet need for contraception at study enrollment 
Unmet need for contraception was calculated per the aforementioned algorithm using 
survey questions around fertility intentions and contraceptive use (Table 3.2). We adapted the 
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algorithm to include fertility intentions, as measures around fertility desires were not captured 
during study follow-up. Because a focus on married or in-union women misses the contraceptive 
practices and needs of sexually active women outside of these partnerships, we opted to 
calculate unmet need for contraception among all who were partnered or sexually active, 
irrespective of marital status.68 Since pregnant and postpartum women were not eligible to 
participate, all women were classified as “not pregnant” at study entry (Table 3.1). As women 
who were knowingly infertile were also ineligible for study entry (Table 3.1), all women were 
considered fecund. All other women who intended to prevent or delay pregnancy at the time of 
study enrollment but were not using a reliable method of contraception were considered to have 
unmet need for contraception at enrollment.  
Measuring unmet need for contraception during follow-up 
During follow-up, time-updated measures of fertility intentions, contraceptive use and 
pregnancy status were re-entered into the algorithm to reflect changes in unmet need at each 
study visit (Table 3.2). Because pregnant women cannot experience the outcome of unmet 
need for contraception, women who became pregnant during follow-up were censored at 
incident pregnancy.  
Measuring fertility intentions at baseline and during follow-up 
Current fertility intentions were assessed at baseline and during follow-up using time-
updated measures (Table 3.2).  
2.5 Predictors  
A variety of a priori specified baseline characteristics were evaluated as potential predictors of 
trajectory group membership. We selected predictors of interest from known clinical and 
behavioral factors associated with unmet need for contraception in HIV-infected women 
identified in a systematic review. Predictors identified in preliminary analyses included: 
demographic characteristics (age, relationship status), measures of wealth or socioeconomic 
status (education, income, recipient of a social grant), having prior children, partner desires 
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a/another child, measures or partner communication (disclosed HIV status to main partner, 
experienced physical intimate partner violence with main partner), measures of provider 
interaction (provider discussed options for future childbearing, provider discussed PMTCT, 
provider discouraged having more children, provider discussed hormonal contraception), HIV-
related clinical outcomes (CD4 count, time on ART) and measures of hormonal contraception 
experience (experienced problems with current contraceptive method of choice, heard of any 
ART/contraceptive interaction). To avoid a potential lack of positivity during modeling, variables 
that informed our definition of unmet need for contraception were excluded from predictor 
analyses.  
2.6 Analytic Plan for Aim 1 
Modeling unmet need for contraception using group-based trajectory models 
Group-based trajectory models are a class of finite mixture models designed to analyze 
data composed of a mixture of two or more groups whose outcomes are thought to be 
generated by distinct statistical processes.31 These models assume that the population of 
interest comprises a mixture of subgroups that follow different developmental trajectories. 
Implicit in group-based trajectory modeling is the assumption that the true distribution of these 
subgroups across population members is unknown. As such, discrete trajectory groups are 
defined to approximate what is likely a continuous population distribution of trajectories of 
unknown shape. These groups can be thought of as latent longitudinal strata, and the shapes of 
the trajectories are described by a polynomial function of age or time. 
Group-based trajectory models are data driven, meaning that only the study data are 
used to identify the number of groups that best fit the data and the shape of the trajectory for 
each group.98 The data also provide an estimate of the proportion of the population whose 
measured behaviors “conforms most closely to each trajectory group”.98 Figure 3.3 provides an 
overview of the general model and its key outputs. 
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Our model follows a binary logit distribution and estimates the probability that individual 

























4     (equation 1) 
 
where 7 is a variable representing age, time or visit number. For instances in which there are 
more than two trajectory groups (as was expected in our analysis), this model generalizes to a 
multinomial logit model.  
In group-based trajectory models, parameter estimates are the product of maximum 
likelihood estimation, and as such are consistent and asymptotically normally distributed.31,99-102 
These parameters maximize the probability of 8&, where 8& denotes a longitudinal sequence of 
measurements from individual ! over 9 time periods. If the parameters were constant across all 
individuals, the expected trajectory of all individuals would be identical. Since group-based 
trajectory models do not assume constancy, trajectories are summarized by a finite set of 
different polynomial functions with differing parameter estimates, where each function 
corresponds with a trajectory group, $. To define trajectories of unmet need for contraception 
over the study period, we used a binomial probability distribution to construct the likelihood 
function. Construction of the likelihood function requires the aggregation of the : conditional 
likelihood functions, ;((8&), to form the unconditional probability of the data, 8&: 
;(8&) = ∑ ?(;((8&)
@
( ,     (equation 2) 
where ;(8&) is the unconditional probability of observing individual !’s longitudinal sequence of 
measurements, 8&. It equals the sum across the : groups of the probability of 8&, given !’s 
membership in group $ weighted by the probability of membership, ?(. Thus, the likelihood for 
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the entire study sample is the product of the individual likelihood functions for the C individuals 
that comprise the sample. 
Model Estimation 
We estimated models using Proc Traj, a free downloadable add-on package to base 
SAS (SAS, version 9.4, Cary, NC). Proc Traj uses a general quasi-Newton procedure to 
implement a search routine to locate the parameter estimates that maximize the likelihood 
function and has been shown to be superior for identifying underlying longitudinal trajectories 
relative to other methods.103,104 
Model Selection 
We used the Bayesian Information Criterion (BIC) to compare models with differing 
numbers of groups, with a smaller BIC corresponding to a better-fitting model.105 The BIC is 
commonly used in the trajectory model literature, and assesses model fit by balancing model 
complexity versus goodness of fit to the sample data. The number of parameters is determined 
by the order of the polynomial (e.g., second order, third order) used to model each trajectory as 
well as the total number of groups. For a given model, BIC is calculated as: 
DEF = GHI(J) − 0.5N	GHI(C)     (equation 3) 
where J is the value of the model’s maximum likelihood, C is the sample size of the study 
population, and N is the number of parameters in the model. The first component of the equation 
measures the improvement in model fit gained by generalizing the model to include additional 
parameters. The second component results in a penalty for the addition of more parameters. 
Thus, the addition of another trajectory group is only warranted if the change in GHI(J) is larger 
than the penalty for adding additional parameters.  
We employed a two-stage model selection process to select the number of groups to 
include in the final model. In the first stage we estimated one model for each possible value of :, 
from one group to a maximum of six groups as is consistent in the trajectory literature.31 Each 
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model was compared with the same order polynomial (e.g. quadratic, cubic) and the number of 
groups in the final model determined for the value : with the highest BIC score. Once : was 
determined, the preferred order of the polynomial specifying the shape of each trajectory was 
selected (second stage). Quadratic and cubic specifications were compared using Jeffreys’s 
scale of evidence for Bayes factors (Table 3.3).105,106 
Calculating Posterior Probabilities of Group Membership 
Posterior probabilities of group membership can be used as an additional method to 
assess model adequacy, and to assign behavioral profiles of trajectory group members. The 
posterior probability of group membership measures the probability that an individual, !, belongs 
to a specific trajectory group, $. Because the posterior probability of group membership cannot 
be calculated directly from the model’s parameter estimates, posterior probabilities are 
calculated using Bayes’s Theorem and weighted by the probability of group membership, ?O(. 
Individuals are then linked to a trajectory group using a maximum-probability assignment rule, 
which assigns individuals into a trajectory group to which their posterior probability is highest. 
Once individuals are assigned, we calculated the average posterior probability of group 
membership (PQR;;), ensuring a mean PQR;; ≥ 0.7 for each trajectory group.  
After individuals were assigned membership to a trajectory group, summary statistics for 
individual characteristics were calculated by group. These summaries create a profile of 
demographics and behavioral characteristics for the “average” group member,98 providing early 
insight into factors associated with group membership.  
Adding Covariates to the Model 
Though calculation of posterior probabilities allowed us to construct profiles of trajectory 
group membership, these profiles are a collection of univariate contrasts that do not control for 
correlations among the predictors. They also do not provide a distinct mathematical relationship 
between the probability of group membership, ?(, and each of the variables of interest. Thus, to 
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formally assess predictors of trajectory group membership, we used an extension of the general 
model that allows the probability of trajectory group membership to depend on a priori specified 
behavioral characteristics (see Predictors). 
We extended the general model (see Modeling unmet need for contraception using 
group-based trajectory models) so that the probability of group membership, ?(, was allowed to 




     (equation 4) 
where S& is a vector of characteristics and	V( are the estimated parameters that capture the 
conditional probability of group membership, ?((S&), in a given group.
98  
We first constructed a multinomial outcome for group membership based on the number 
of groups identified by the final predictor-free model. We then assigned women to a specific 
trajectory group based on their maximum posterior membership probability. We then fit a 
multinomial regression model with this assigned trajectory group as the outcome and the 
predictors of interest as explanatory variables. Covariates were removed from the full model 
using a “backward” selection procedure.107 Once a final set was identified, we re-estimated the 
trajectories jointly with the predictors. We included this second stage to ensure that our 
coefficients and standard errors properly accounted for covariance between parameter 
estimates and the probabilities of membership in each trajectory group. To determine how large 
an impact each characteristic has on the probability of group membership, and the extent to 
which these characteristics predict an individual’s trajectory group membership, we calculated 
odds ratios and predicted probabilities using our optimal trajectory as the referent.  
2.7 Power and Sample Size Considerations 
All analyses for Aim 1 are descriptive, obviating the need for a formal power 
assessment. The key sample size questions for Aim 1 relate to precision and power to identify 
differences in trajectory groups. We anticipated that the repeat measurements collected among 
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the 850 women in our available sample were sufficient to yield precise estimates and to detect 
meaningful differences in trajectory group membership. 
2.8 Missing Data  
Complete case analysis may be valid if the amount of missingness is small (less than 
10%).108 For all predictors of interest, we elected to use complete case analysis as missing data 
accounted for less than 3% of observations. For missing values of unmet need for 
contraception, we re-estimated trajectories using quarterly intervals assessments (every three 
months). This approach minimized missing data resulting from our choice to finely measure 
unmet need for contraception every month.  
2.9 Additional Analyses  
This investigation primarily focused on characterizing trajectories of unmet need for 
contraception in a real-world population of HIV-infected women engaged in HIV care, and study 
enrollment was our origin for main analyses. In sub-analyses, we restricted trajectory models to 
women who had initiated ART within three months of study enrollment (“recent initiators”) to 
better identify distinct trajectories of unmet need for contraception in the immediate period 
following ART initiation. Models were fit systematically using the same processes as described 
for the full cohort.  
We hypothesize that contraceptive need, and by extension unmet need for 
contraception, varies over a short-term 12-month period.  Central to this hypothesis is the notion 
that fertility intentions, contraceptive use, or both also vary over the study period. To evaluate 
the potential volatility of these measures, conducted an additional descriptive analysis to 
characterize potential differences in fertility intentions and contraceptive use by trajectory group 
over the study period. To do so, we used a maximum-probability assignment rule to assign 
women to the trajectory group for which they had the highest predicted posterior probability from 
the best fitting model.31,102  We then descriptively examined the proportion of women trying to 
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conceive and the proportion of women using hormonal contraception within each interval, 
stratified by trajectory group. 
Group-based trajectory models provide an empirical means of identifying groups or 
clusters of individuals following distinct developmental progressions over a given period.31 In 
contrast, more standard statistical methods of longitudinal data analysis are designed to 
account for individual variability about a mean population trend.102 To further assess the utility of 
the “finite mixture modeling” approach employed by group-based trajectory models in identifying 
heterogeneity, we simultaneously fit a log-binomial model for unmet need for contraception and 
generated prevalence estimates at repeat intervals over the study period. Results were visually 
presented and compared with results from the group-based trajectory models.  
2.10 Sensitivity Analyses 
Though a high proportion of women were retained through the end of the study period, 
we induced some missingness during follow-up visits by finely measuring unmet need for 
contraception every month. We did this to maximize the number of time points included in the 
group-based trajectory models so that we could infer granular changes in the predicted 
probability for unmet need for contraception over the entire study period. In sensitivity analyses 
for both the full cohort and recent initiators, we re-estimated trajectories using quarterly intervals 
assessments (every three months) to minimize missing data. 
Unmet need for contraception was measured during routine HIV clinical care visits, and 
women who changed their fertility intentions following their previous care visit may have been 
misclassified as having unmet need for contraception. Specifically, women who became 
pregnant during follow-up may have changed their fertility intentions (from not trying to trying) 
prior to conceiving, but this change may not have been detected by our study’s design as 
women were censored at pregnancy. To account for potential informative censoring at time of 
pregnancy resulting from this unmeasured change in fertility intentions, we repeated our main 
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analysis and restricted our cohort to those women who did not become pregnant during follow-
up.  
3. Approach for Aim 2 
3.1 Overview 
To better understand how childbearing decisions affect a woman’s relationship with HIV 
care, we estimated the effect of fertility intentions on attendance at clinic visits over the 12-
month study period. To estimate odds ratios for attendance at clinic visits, we fit a series of 
generalized linear models using generalized estimating equations (GEE) to account for repeat 
observations within women. We censored women at pregnancy. We adjusted models for a 
minimally sufficient set of confounders as identified by a directed acyclic graph (DAG), and 
explored potential effect measure modification (EMM) by select clinical characteristics identified 
a priori.  
3.2 Study Design 
This aim is a secondary analysis of a previously conducted prospective cohort study, 
“Pregnancy Intentions and Incidence in HIV Positive Women on Antiretroviral Therapy in South 
Africa”. All analyses were conducted among the 850 HIV-infected women who were previously 
on or being initiated on ART during study enrollment. Our origin was defined as the date of 
original study enrollment, and characteristics were assessed at enrollment via interviewer-
administered questionnaire. Follow-up began at study entry (“Month 0”) and concluded at the 
completion of 12 months. The frequency of follow-up varied per woman depending on provider 
scheduling, clinic recommendations or provincial ART supply; however, women were 
recommended to attend HIV clinical care visits every three months, at minimum.32  
3.3 Study Population 
The study population included all 850 HIV-infected women who were previously on or 
being initiated onto ART originally enrolled in the parent study. Women were eligible at study 
enrollment if they: were older than 18 but less than 35 years of age, not pregnant or 
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breastfeeding, had not delivered a pregnancy in the previous three months, were taking ART, 
were sexually active within the past 12 months, had previously undergone a tubal ligation, 
hysterectomy, bi-lateral oophorectomy or were diagnosed as permanently infertile (Table 3.1).  
3.4 Exposure Measures 
The objective of this analysis was to determine if fertility intentions affect a woman’s 
relationship with HIV care. We hypothesized that women who intend to become pregnant 
would have a more consistent relationship with care compared to women who intend to 
prevent or delay pregnancy. We considered fertility intentions our exposure of interest.  
Time-fixed fertility intentions were assessed categorically at study enrollment as a 
measure of whether or not a woman was trying to conceive at time of interview (yes/no), trying 
to conceive in the next 12 months (yes/no/maybe), or trying to conceive at some point in the 
future (Table 3.2).  
Time-varying fertility intentions were assessed dichotomously during follow-up (Table 
3.2). Women were asked at each visit if they were currently trying to conceive (yes/no). We 
compared those women who were trying to conceive with those who were not at each visit. 
3.5 Outcome Measures 
The primary endpoint in this analysis is attendance at clinic visits over the 12-month 
period of observation. Attendance at clinic visits may be used as a measure of retention,112 
and indicates a period of interruption or engagement in HIV care for a given interval of time. The 
measure captures the number of “no show” visits during an observation period of interest. In our 
study, follow-up visits coincide with routine clinical care visits every 1-3 months based on clinic 
protocol, provider recommendations and provincial ART supply. Because date of next clinic visit 
was not routinely collected during the study period, a “days late” or traditional “missed 
appointments” definition of attrition is not feasible for our study; however, attendance within 
defined intervals or periods can be readily determined (Figure 3.4). As all women in this analysis 
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were on or being initiated onto ART, we measured attendance at clinic visits in repeat, discrete 
three-month intervals. A “no show” constituted a failure to return to clinic within a given interval. 
Because women may eventually return to care, multiple intervals of missed visits are possible 
over the course of the 12-month period. As our interest was in characterizing women with one or 
more missed visits over a short-term period, the primary endpoint of interest for this analysis 
was a dichotomized measure of whether or not a woman attended a visit within a given interval 
(yes/no), captured at repeat study visits over time. Administrative censoring occurred at the 
completion of 12 months, known transfer date, un-enrollment from the study, or date of death. 
Additionally, women who became pregnant during the study were referred to antenatal care 
(ANC), and censored date of confirmed pregnancy.  
3.6 Confounders and Effect Measure Modifiers  
We used covariate adjustment to balance the distribution of time-fixed characteristics 
captured at study enrollment for each exposure outcome relationship. A minimally sufficient set 
of covariates for adjustment was identified using a directed acyclic graph (DAG) (Figure 3.5): 
Age: 30,113-115 Age at study entry  
Time-on-ART:114,116,117 Time spent on ART prior to study entry 
Partner fertility intentions: Partner wants a/another child 
Postpartum status: 9,11,115 End of last known pregnancy occurred ≤6 months prior to study 
entry 
Prior children: 113,114,116,118 Number of children currently living 
Provider discouraged childbearing: Provider discouraged having a/another child 
Relationship status: 114,119 Married, living with a partner, widowed, separated or divorced 
In preliminary analyses, no covariates were identified as potential time-varying confounders. 
We suspect this was because our exposure was not affected by HIV clinical outcomes (e.g., 
HIV-1 RNA viral load, CD4 cell count) in our assessment of the literature. Both pregnancy and 
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use of hormonal contraception were identified as intermediate factors on the causal pathway 
between each measure of fertility intentions and attendance at HIV clinical care visits (Figure 
3.5). As our interest lies in estimating the total effect of fertility intentions on attendance, we 
opted not to formally control for pregnancy or contraceptive use in this analysis. 
3.7 Analytic Plan for Aim 2 
Overview of Analytic Approach 
Percentages for discrete characteristics and medians and quartiles for continuous 
characteristics were calculated for women at study entry and stratified by dichotomous time-
fixed fertility intentions (trying to conceive in the next 12 months vs. not) captured at enrollment. 
Fisher’s exact test was used to compare the differences in proportions between arms for 
categorical variables, and Wilcoxon rank-sum tests were used to compare medians for 
continuous data (with alpha 0.05). To estimate the effect of fertility intentions on attendance at 
clinic visits, we used GEE with a logistic link to estimate odds ratios and predicted probabilities. 
We used a time-lag model to account for time-varying fertility intentions captured during follow-
up.  
Estimating the Effect of Time-Fixed Fertility Intentions on Attendance 
We used GEE with a logistic link to estimate the effect of time-fixed fertility intentions 
captured at study enrollment on the odds of missing an HIV clinical care visit over the study 
period. We compared women who were trying to conceive (at study enrollment or in the next 12 
months) with those that were not trying to conceive. Robust variance estimators with an 
exchangeable correlation matrix were used to account for within-subject correlation. We 
adjusted for the minimally sufficient set of confounders identified in DAG analyses.  
Estimating the Effect of Time-Varying Fertility Intentions on Attendance 
We similarly used GEE with a logistic link to estimate the effect of time-varying fertility 
intentions on the odds of missing an HIV clinical care visit over the study period. We compared 
women who were trying to conceive at each visit with those that were not. To ensure a woman’s 
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fertility intentions preceded her attendance assessment for a given interval, we used the value 
of her fertility intentions from the preceding interval during modeling. To account for missing 
exposure data, we considered both complete case analysis and inverse probability weighting. 
Assessing Effect Measure Modification  
Since our study sample comprises women with a variety of ART experiences, we also 
assessed potential effect measure modification (EMM) by time-on-ART, age and CD4 count. 
For each potential modifier we dichotomized fertility intentions, comparing those women that 
were trying to conceive at enrollment with those that were not (current fertility intentions) and 
comparing women that had plans to conceive with those who had no plans to conceive (any 
fertility intentions). 
To assess EMM by ART duration, we compared women who had initiated ART within 
three months of study enrollment (recent initiators) with those that had been on ART for more 
than three months (ART experienced). Our cutoff of three months was used to approximate 
those who had started ART on or around the time of study entry. Age was categorized about the 
median of 30 years and CD4 count was categorized about the common threshold of 200 
cells/µl. To formally test for effect measure modification, we included an interaction term 
between each dichotomized exposure of fertility intentions and each of the proposed modifiers, 
where interaction terms with Wald test statistic p-values of <0.10 were considered significant. 
We considered both the magnitude and precision of stratum-specific estimates when making a 
final determination of EMM. 
3.8 Power and Sample Size Considerations 
We parameterized our power calculation for a simple logistic regression model, 
estimating the odds ratio for the association between current fertility intentions (dichotomized as 
trying to conceive vs. not trying to conceive) and attendance at HIV clinical care visits. As 
longitudinal, repeated measures typically allow for higher statistical power than cross-sectional 
designs, our power calculation represents a conservative estimate of the statistical power 
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afforded by our study. We assumed a two-sided test for the statistical significance of the 
likelihood ratio chi-square statistic at alpha=0.05 and a total sample size of 850. We assumed 
that 30% of women were trying to conceive at enrollment, and that the proportion of those not 
trying to conceive averaged 70% attendance at HIV clinical care visits, as estimated by external 
data that report high attendance at HIV clinical care visits 12 months after ART initiation.120 
Finally, we varied the expected odds ratios from 1.1 to 2.0 to cover a range of plausible effect 
estimates in the hypothesized direction. Figure 3.5 shows the power curve over the range of 
odds ratios above the null. Overall, for all odds ratios greater than 1.65 we maintained a 
statistical power above 80% to estimate the effect of fertility intentions on odds of attendance at 




4. Tables and Figures 
TABLE 3.1 Characteristics of parent study 
Objective The objectives of the parent study were to: 
1) Determine the incidence of pregnancy in HIV-infected women on antiretroviral 
therapy (ART) in South Africa; and  
2) Assess contraceptive use and associations with unplanned pregnancy in this 
population. 
Study Design Prospective cohort study 
Study 
Population 
850 non-pregnant, HIV-infected women aged 18 to 35 enrolled on ART who initiated 
treatment with CD4 count ≤200 cells/μl or WHO clinical stage 4 diagnosis 
Eligibility 
Criteria  
Between 18 and 35 years of age (inclusive); 
Not pregnant at time of study enrollment; 
Had not delivered a pregnancy within the three months preceding study enrollment; 
Not breastfeeding; 
Enrolled on ART or initiated ART at study enrollment; 
Sexually active within the 12 months preceding study enrollment; 
No previous tubal ligation, hysterectomy, bi-lateral oophorectomy; 
Not diagnosed as permanently infertile. 
 
 
TABLE 3.2 Assessment of characteristics used to calculate unmet need for 
contraception 
Characteristic Measure Timing of Assessment 











Family planning method currently being used. 
Enrollment: Open-ended and categorized by 
interviewer 
Follow-up: Participant self-reported (Oral 






Currently using reliable contraceptive method for 
family planning (yes/no). Includes oral 










If not currently trying, planning to become pregnant 
in the next 12 months (yes/no) 
X  
If not currently trying or planning to become pregnant 









TABLE 3.3 Jeffreys’s scale of evidence for Bayes factors 
Bayes factor Interpretation 
WXY < [/[] Strong evidence for model $ 
[/[] < WXY < [/^ Moderate evidence for model $ 
[/^ < WXY < [ Weak evidence for model $ 
[ < WXY < ^ Weak evidence for model ! 
^ < WXY < [] Moderate evidence for model ! 
WXY > [] Strong evidence for model ! 
`!$ is the Bayes factor, and measures the posterior odds of ! being the correct model given the 
data relative to $.	`!$ is approximated as Rabc1dabc-. Adapted from Nagin, DS (2005). 
 
 














Pregnant or postpartum amenorrheic
(period not returned since last 
live birth in the last 2 years)
Not pregnant or postpartum 
amenorrheic
Said “can’t get pregnant” on wantedness of 
future children=INFECUND
Married 5+ years ago, had
no children in past 5 yrs, and never used 
contraception=INFECUND
Response to time since last period is “last 
period was before birth” and last birth 5+ 
yrs ago=INFECUND
Said “menopausal/hysterectomy” on reason 
not using contraception= INFECUND
Response to time since last period is ≥6 
months and not postpartum amenorrheic
(0-59 months)=INFECUND
Response to time since last period is 






Wants next child in 2+ yrs;
Wants child and undecided
timing, or undecided
If wants child=























































Adapted from Bradley, SEK et al. (2012).68 
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In-union or sexually active in the three months
Wants more 
children, but not 
trying to conceive= 












FIGURE 3.4 Attendance at HIV clinical care visits for a hypothetical patient 
 
Note: An “x” denotes that the patient had a clinic visit in the corresponding month. A missed visit was 
defined as having no clinic visit in a three-month period. The first period (Q1) begins on the first day of the 
first month directly preceding study entry (Month 0). In this example, the patient had one clinic visit in the 
first period (Q1), one clinic visit in the second period (Q2), and one clinic visit in the second period (Q4). 
The patient did not attend in Q3 (adapted from Byrd KK et al., 2015)121 
 
FIGURE 3.5 Directed acyclic graph (DAG) depicting the hypothesized relationship 








FIGURE 3.6 Expected statistical power to explore the association between fertility 

























CHAPTER IV: AIM 1
 
Longitudinal patterns of unmet need for contraception among HIV-infected women on ART in 
Johannesburg, South Africa 
 
1. Introduction 
In HIV-infected women, prevention of unintended pregnancy through reliable 
contraceptive methods improves women’s health and reduces both maternal and infant 
mortality.1,2 Prevention of unintended pregnancy is also an effective strategy to reduce mother-
to-child transmission,3 and is the second prong of WHO’s four-pronged framework for 
prevention of mother-to-child transmission (PMTCT).4  For these reasons and to ensure 
women’s reproductive rights, South African national contraception and family planning 
guidelines promote the availability of accessible and comprehensive contraceptive services to 
meet the family planning needs of women living with HIV.5 In practice, however, HIV-infected 
women in South Africa still experience tremendous difficulties meeting their family planning 
needs.6-9 
Family planning needs of HIV-infected women are likely to change over time, yet these 
changes may go undetected due to facility- and provider-level factors that preclude providers 
from routinely assessing fertility preferences and contraceptive use in the context of HIV clinical 
care. Comprehensive programs to reduce unmet need for contraception in HIV-infected women, 
broadly defined as a discrepancy between expressed fertility preferences and contraceptive 
use,10 have traditionally focused on improving availability of services, increasing education and 
information dissemination around contraceptive use, and strengthening contraceptive 
counseling at the provider level.7,11-14 However, even in settings where these enhanced family 







and health-facility factors such as high patient volume and limited number of providers can 
affect patient-provider interaction time and quality of care. 16,17 To the extent that fertility 
intentions and contraceptive use are dynamic, this presents a missed opportunity for 
intervention. 
Delineating patterns of unmet contraceptive need in HIV-infected women could help 
providers better understand the extent to which the risk for unintended pregnancy is likely to 
change over time. Furthermore, characterization of temporal trends or predictors of unmet need 
for contraception could inform more targeted screening practices within integrated reproductive 
health and antiretroviral therapy (ART) services, including both contraception provision and 
safer conception interventions. We assessed the longitudinal patterns of unmet need for 
contraception over a 12-month period within a cohort of HIV-infected women taking ART in 
South Africa. 
2. Methods 
2.1 Study Setting, Population and Design 
Data were prospectively collected from four public-sector HIV outpatient clinics in inner 
city Johannesburg between 2009 and 2011 as part of a larger study to estimate the 12-month 
incidence of pregnancy in HIV-infected women on ART. Full study procedures and eligibility 
criteria have been previously described.8,15,18  In brief, all HIV-infected, non-pregnant, sexually 
active women between the ages of 18-35 on or initiating ART were eligible for participation if 
they had not given birth in the last three months, were not breastfeeding, had not had a previous 
tubal ligation, hysterectomy, bi-lateral oophorectomy, and had not received a diagnosis of 
permanent infertility. Pregnancy was determined using urine-based tests administered by study 
staff (One Step hCG Urine Pregnancy Test, Atlas Link Technology, Beijing) and confirmed 
through repeat testing. ART regimen information, CD4 cell count and viral load data were 
confirmed through medical record review, pharmacy and laboratory records. After providing 







administered questionnaire to assess demographic and behavioral characteristics including 
fertility history and intentions, contraceptive use, and sexual risk behaviors.  
2.2 Outcome Definition 
Our outcome of interest was unmet need for contraception (yes/no), which we assessed 
at the time of each routine care visit according to an algorithm modified from that of Bradley et 
al.19  Specifically, women were considered to have unmet need for contraception at a given 
study visit if they reported 1) being married, living with a partner, or being sexually active in the 
three months preceding study enrollment; 2) not currently trying to become pregnant; and 3) not 
currently using oral contraceptives, injectable, a hormonal implant or an intrauterine device. 
Women who met the first two criteria and reported condom use as their primary family planning 
method were considered to have unmet need, as rates of unintended pregnancy are 
comparable among women who do not use family planning methods and among those who 
report condom use alone.8,20   
 We assessed unmet need for contraception at monthly intervals after enrollment, 
corresponding to the routine care visits, for a total of 12-time points. In cases where a woman 
had two routine care visits within a given month, we employed a two-stage process for 
measurement selection. If another visit occurred in the subsequent interval, we retained only the 
first measurement for the month in question. If, however, no visit occurred in the next interval, 
we retained both measurements for the month in question provided they occurred at least 21 
days apart, and assigned the second value forward to the next interval. This process accounted 
for the heterogeneity in clinic visit frequency among women, minimized missing data, and 
reflected any conflicting, individual measurement within a given interval. Women were censored 
at pregnancy, loss to follow-up, death, or the completion of 12 months of follow-up.   
The original study protocol was approved by the University of the Witwatersrand Human 







obtained from all participants. The University of North Carolina at Chapel Hill Institutional 
Review Board also approved the secondary analysis presented here. 
2.3 Statistical Analysis 
We used group-based trajectory modeling to identify distinct longitudinal patterns of 
unmet need for contraception over the 12-month period.21,22 Group-based trajectory modeling is 
an application of finite mixture modeling designed to identify clusters of individuals who follow a 
similar trajectory for a given outcome over time.22 We first fit a series of predictor-free trajectory 
models to identify the optimal number of trajectories describing the population patterns of unmet 
need for contraception, fitting models with 2, 3, 4, or 5 trajectory groups to allow for 
heterogeneity while ensuring interpretability.  Given the dichotomous nature of the outcome, we 
specified a logit link and binomial distribution, and we decided a priori to consider both quadratic 
and cubic specifications of each model to enable flexible trajectory shapes. We chose the 
optimal model based on optimum Bayesian information criterion (BIC) using Jeffreys’s scale of 
evidence for Bayes factors.23,24 
As unmet need for contraception is a function of both fertility intentions and 
contraceptive use, changes in unmet need may reflect changes in fertility intentions, 
contraceptive use, or both.  Therefore, to delineate changes in the separate phenomena 
contributing to the composite outcome of unmet need for contraception, we conducted a 
descriptive analysis in which we graphically characterized both fertility intentions and 
contraceptive use over the study period.  At each interval we assigned women to one of four 
mutually exclusive categories:1) those who had unmet need according to the definition above; 
2) those who were married, living with a partner, or sexually active and using a reliable method 
of contraception to prevent pregnancy; 3) those who were married, living with a partner, or 
sexually active and trying to conceive, and 4) those who were not married, living with a partner, 
or sexually active. We conducted this descriptive analysis overall and by trajectory group 







To identify predictors of trajectory group membership, we first constructed a categorical 
outcome for group membership based on the final predictor-free model, assigning each woman 
to a group based on her maximum posterior membership probability in each model.21,22 We then 
fit a multinomial regression model with this assigned trajectory group as the outcome and the 
predictors of interest as explanatory variables. Predictors of interest were clinical and behavioral 
factors associated with unmet need for contraception in HIV-infected women as identified 
through a literature review. All predictors of interest were assessed at enrollment and are 
included in Tables 4.4 and 4.5. Predictors included demographics, measures of fertility history, 
partner-associated characteristics, measures of patient/provider interaction and HIV-related 
clinical outcomes. 
In a second stage of the predictor analysis, we constructed a new group-based trajectory 
model for unmet need for contraception, retaining all predictors that were found to be significant 
(a=0.1) for at least one trajectory group comparison in the first stage.21 We included this second 
stage to ensure that our coefficients and standard errors properly accounted for covariance 
between parameter estimates and the probabilities of membership in each trajectory group.21 
We conducted all analyses in the full cohort and repeated them in a subgroup of women 
initiating ART within 3 months of enrollment, given the likelihood that fertility intentions may 
change rapidly immediately after ART initiation 25-27, as well as the distinctness of ART initiation 
as a clearly identifiable developmental origin and intervention point. In sensitivity analyses for 
both the full cohort and recent initiators, we re-estimated trajectories using quarterly interval 
assessments (every three months). All models were fit using Proc Traj 
(https://www.andrew.cmu.edu/user/bjones/index.htm) a free downloadable SAS add-on 
package (SAS, version 9.4, Cary, NC). 
3. Results 
3.1 Study Population and Follow-Up 







month period, 149 women (17.5%) became pregnant and contributed a median of 6.2 months 
(IQR 4, 9) of follow-up before they were censored at time of pregnancy. Among the 701 women 
who did not become pregnant, median follow-up time was 11.4 months (IQR 9, 12), with 28 
(4.0%) not returning to care after their initial study visit. Median time between follow-up visits 
was 1.7 months (IQR 1, 2) for women who became pregnant and 1.8 months (IQR 1, 2) for 
those who did not. No deaths were reported over the study period.  
 Women were on average 30 years of age (IQR 27, 33), and the majority were in a 
relationship (789/850, 92.8%) (Table 4.1). Most women (760/850, 89.4%) had previously been 
pregnant, with a median time since last pregnancy of 48 months (IQR 20, 96). The median time 
since HIV diagnosis was 24 months (IQR 12, 48), and median time since ART initiation was 13 
months (IQR 5, 24).  
 Of the 850 women in the full cohort, 157 (18.5%) had initiated ART within three months 
of study enrollment (“recent initiators”) and 693 (81.5%) had initiated ART more than three 
months prior to study enrollment (“ART experienced”). Demographics, behavioral characteristics 
and clinical characteristics differed by ART experience. Compared to ART-experienced women, 
a larger proportion of recent initiators reported at enrollment that they planned to become 
pregnant in the next 12 months (97/157 (61.8%) vs. 299/693 (43.2%)) and a smaller proportion 
were using hormonal contraception (21/157 (13.4%) vs. 203/693 (29.3%)) to prevent pregnancy.  
Unmet need was assessed at study enrollment in both the full cohort and in recent ART 
initiators. Of the 850 women included in the full cohort, 469 (55.2%) had unmet need. The 
proportion of women with unmet need was similar among recent initiators of ART compared to 
women who were ART experienced (54.1% vs. 59.9%). 
3.2 Longitudinal Assessment of Unmet Need for Contraception 
A four-group quadratic model was selected as the optimal predictor-free model to 
identify patterns of unmet need over 12 months (Figure 4.1a). Half (50.0%) of the cohort was 







need between 79.0% and 98.0%) over the study period. Nearly a quarter (22.9%) were 
predicted to have a consistently low probability of unmet need (1.2%-8.0% probability of unmet 
need over time). Additionally, 16.7% had a steadily decreasing probability of unmet need (from 
86.9% at month 0 to 3.1% at month 9) and 10.4% exhibited a sharp increase in this probability 
(from 6.0% at month 0 to 81.4% at month 12). Based on these trends for unmet need, we 
qualitatively described these groups as “consistently high,” “consistently low,” “decreasing,” and 
“increasing,” respectively. 
In the sub-analysis of recent ART initiators (n=157), a four-group, predictor-free cubic 
model was selected to identify patterns of unmet need (Figure 4.1b). Similar to the model 
selected for the full cohort, nearly half (40.8%) of recent initiators were predicted to have a 
consistently high probability of unmet need (predicted probability of unmet need between 91.1% 
and 96.9% throughout). Women who were predicted to have a consistently low probability of 
unmet need (between 0.0% and 14.6% across the 12 months) accounted for 24.4% of recent 
initiators. Nearly a quarter (17.5%) of recent initiators were predicted to have a slowly increasing 
probability of unmet need (from 25.1% at month 3 to 94.5% at month 12), and a nearly identical 
proportion (17.4%) were predicted to have a decreasing probability of unmet need (from 88.3% 
at month 1 to 16.9% at month 9). 
 In sensitivity analyses where we re-estimated trajectories using quarterly intervals 
assessments, results were generally similar (Figure 4.3).  Results were also similar in sensitivity 
analyses where we excluded women who became pregnant during follow-up (Figure 4.4) 
3.3 Fertility Intentions and Contraceptive Use Over Time 
Temporal patterns in the two distinct contributors to unmet need – fertility intentions and 
contraceptive use – varied dramatically across trajectory groups (Figure 4.2). In those who 
followed an increasing trajectory of unmet need (based on assignment to the increasing group 
using a maximum posterior membership probability), the proportion trying to conceive 







using reliable contraception to prevent pregnancy (from 61.6% in month 0 to 13.8% in month 
12). In those who followed a decreasing trajectory of unmet need, the proportion trying to 
conceive increased over time (between 3.5% at month 0 and 45.5% at month 12) and the 
proportion using reliable contraception to prevent pregnancy also increased (between 4.3% and 
16.9% over the 12 months). For women who followed trajectories of unmet need that were 
relatively constant (i.e. consistently low and consistently high), we observed little change in 
fertility intentions and contraceptive use over the 12 months. Results were similar in recent 
initiators. 
3.4 Predictors of Trajectory Group Membership 
Our multinomial logistic regression analysis allowed comparison of predictors for each of 
the four trajectory groups relative to each other group (i.e., sixteen possible comparisons). For 
simplicity, we focus here on the two main comparisons of greatest apparent clinical relevance. 
Specifically, based on our observation of similar “starting points” for the consistently high and 
decreasing trajectories (and for the consistently low and increasing trajectories), we describe 
predictors associated with membership in the decreasing group (compared to the consistently 
high group) and those associated with membership in the increasing group (compared to the 
consistently low group), as found using the two-stage process outlined above. Compared to the 
consistently high unmet need group, those in the decreasing group were likely to have fewer 
children (OR 0.4, 95% CI 0.3, 0.5) for each one-unit increase in number of living children) and 
were more likely to have a partner that desired a/another child (OR 4.2 95% CI 1.6, 10.9) (Table 
4.2). Compared to the consistently low group, women in the increasing group were more likely 
to have reported a problem with their contraceptive method (OR 3.0, 95% CI 1.4, 6.6) (Table 
4.3).  
In analyses confined to recent initiators, we were unable to identify meaningful predictors 
of group membership in stage one due to the limited number of women assigned to each 







trajectory group membership for both the full cohort and recent initiators are reported in Tables 
4.4 and 4.5. 
4. Discussion 
Changes in fertility intentions following ART initiation, coupled with improvements in 
fecundity20,28 and renewed sexual desire and greater coital frequency25 are thought to contribute 
to increasing incidence of pregnancies in HIV-infected women after starting ART in the absence 
of compensatory contraceptive use. In this study, we demonstrated that HIV-infected women on 
ART in South Africa have a high probability of unmet need for contraception, and that rapidly 
changing fertility intentions and decisions about contraceptive use contribute to changing unmet 
need in a non-trivial subset of women.  
 Half of women in our full cohort were predicted to have a consistently high probability of 
unmet need that persisted over time. Approximately one in ten women in our full cohort and 
almost 20% of those recently initiating ART were predicted to have unmet contraceptive need 
that increased over time, indicating they were at higher risk of unintended pregnancy as time 
under observation increased. Notably, among women with increasing unmet contraceptive 
need, few were observed to have unmet need at study enrollment (Figure 4.4). Our findings are 
compatible with previous research showing a single assessment of contraceptive need is 
insufficient in identifying those at high risk for unintended pregnancy, even within a 12-month 
period.8  
Consistent with other estimates of contraceptive use in South Africa, few women in our 
study were using a reliable method of contraception to prevent pregnancy at enrollment. Low 
uptake of hormonal contraception may reflect fear of side effects or health risks (e.g., heavy 
menstrual bleeding, irregular bleeding, bleeding between periods, lower abdominal pain), which 
are strongly associated with contraceptive discontinuation or switching in HIV-infected women in 
multiple studies.29,30,31 Compared to women in our study who followed a trajectory of 







more likely to report problems or side effects with their method of contraception.  Furthermore, a 
significant proportion of those who followed an increasing trajectory of unmet need discontinued 
their method of contraception over the 12-month period without a corresponding change in 
fertility intentions. 
Changes in unmet need for contraception also reflect changes in fertility intentions. We 
found that among women with a decreasing unmet need for contraception over follow-up, the 
primary driver of reduced unmet need was increasing fertility intentions, not an increase in 
uptake of contraception. Previous studies have found that fertility intentions increase rapidly in 
the period following ART initiation,25-27 though evidence is limited. Increasing fertility intentions 
among women on ART may also reflect partner fertility desires, and we found that women with a 
decreasing unmet contraceptive need were more likely to report a partner that desired a/another 
child. To the extent that fertility intentions reflect decisions around childbearing in both partners, 
comprehensive screening of family planning needs including asking women about their partner’s 
fertility intentions, may offer additional opportunities to identify women who require safer 
conception counseling.  
We observed that family planning needs of HIV-infected women changed frequently over 
time in this South African setting, yet in clinical practice fertility intentions and contraceptive use 
were infrequently assessed. While current national service delivery guidelines promote the 
integration of sexual and reproductive health services with HIV prevention, care and treatment 
in South Africa,5 implementation of these guidelines in clinical practice has been limited.32,33 
Routine HIV clinical care visits represent a potential opportunity to regularly assess family 
planning needs, particularly among women on ART who may be unaware that their fertility will 
increase once started on ART. 20,28,34 Furthermore, regularly assessing the family planning 
needs of women who have trouble achieving viral suppression is critical for both prevention of 
horizontal transmission to HIV-uninfected partners and PMTCT. Our findings suggest that 







increase patient and provider awareness about contraceptive side effects and alternative 
method options, and provide high-quality provider training on contraceptive methods and safer 
conception will be most effective in decreasing unmet need for contraception in HIV-infected 
women. 
Our study is not without limitations. First, nearly half of women in this analysis reported 
condoms as their primary method of family planning at enrollment but were considered to have 
unmet need for contraception.  As some of these women may have used condoms consistently 
and correctly, we may have overestimated the total number of women in our cohort with unmet 
need. However, women in this study who reported using condoms had nearly identical 
pregnancy rates as women who reported using no contraceptive method,8 suggesting that the 
majority of women using condoms were not doing so effectively enough to prevent pregnancy. 
Second, all behavioral outcomes were measured by self-report and are subject to potential 
misclassification; however, questionnaires were administered in private by trained study staff 
who developed a strong rapport with the participants to minimize social desirability bias. Third, 
an emerging body of evidence suggests that binary measures of fertility intentions are 
insufficient to capture ambivalence around childbearing,35,36 and we may have overestimated 
unmet need in some women who indicated they were not trying to become pregnant at a given 
study visit.10 Fourth, data included in this study predate South African national service delivery 
guidelines for integrated family planning and HIV care and earlier thresholds for treatment 
initiation. At the time of study enrollment, non-pregnant women were only eligible for lifelong 
ART initiation with a CD4 count ≤200 cells/μl or WHO clinical stage 4 diagnosis, and trajectories 
of unmet need and predictors thereof may differ in the current era. However, we saw very little 
difference in CD4 count by trajectory group. Furthermore, trajectories were largely similar 
among recent ART initiators who started treatment for their own health.  
We have shown that the family planning needs of HIV-infected women may change 







period. As more and more women initiate ART through South Africa’s universal testing and 
treatment inititiative,37 routine screening of fertility intentions combined with rapid service referral 
for reliable contraception and safer conception methods will be critical in ensuring that HIV-









5. Tables and Figures 
 
 
TABLE 4.1 Characteristics at enrollment of 850 HIV-infected women taking ART in 


















Age (years) 30.4 27-33 30.5 28-33 30.0 26-32 









No. living children 1.0 1-2 1.0 1-2 1.0 0-2 
Months since last pregnancy 48.0 20-96 48.0 18-84 72.0 26-96 
Months since HIV diagnosis 24.0 12-48 28.0 15-48 11.0 3-24 
CD4 count at enrollment 
(cells/µl) 
312.0 178-462 356.0 242-510 149.0 87-179 
Months on ART 13.0 5-24 16.0 9-29 1.0 0-2 
 n % n % n % 
Education completed       
None-Grade 10 55 6.5 44 6.4 11 7.0 
Grade 11-Grade 12 671 78.9 542 78.2 129 82.2 
Post-grad degree or certificate 124 14.6 107 15.4 17 10.8 
Employed 510 60.0 427 61.6 83 52.9 
Married/cohabitating with a 
partner 
378 44.5 300 43.3 78 49.7 
In a relationship 789 92.8 655 94.5 134 85.4 
Sexually active, last three 
months 
754 89.4 627 91.0 127 82.5 
Partner HIV status‡       
Negative 200 25.3 165 25.2 35 25.7 
Positive 312 39.4 260 39.7 52 38.2 
Unknown 279 35.3 230 35.1 49 36.0 
Ever pregnant 760 89.4 630 90.9 130 82.8 
Pregnant at HIV diagnosis 271 31.9 248 35.8 23 14.7 
Pregnant at or after HIV 
diagnosis 
380 44.7 347 50.1 33 21.0 
Trying to conceive, currently 105 12.4 83 12.0 22 14.0 
Trying to conceive, next year 396 46.6 299 43.2 97 61.8 
Taking hormonal contraception 224 26.4 203 29.3 21 13.4 
Using condoms for family 
planning 
410 48.2 325 46.9 85 54.1 
Abbreviations; IQR: Interquartile Range, ART: Antiretroviral therapy 
* On ART >3 months at study entry 
† Initiated ART within three months of study entry 








TABLE 4.2 Odds Ratios (95% Confidence Intervals) associated with membership in the 
“Decreasing” unmet need trajectory group (N=850) 
 OR (95% CI) 
Characteristic Consistently High Decreasing Increasing Consistently Low 
Number of living children* 1 0.4 (0.3, 0.5) 0.6 (0.4, 0.9) 0.6 (0.4, 0.7) 
Employed 1 1.7 (0.9, 3.0) 1.9 (0.8, 4.4) 1.5 (0.9, 2.7) 
Main partner desires 
a/another child 
1 4.2 (1.6, 10.9) 0.5 (0.1, 2.9) 0.8 (0.5, 1.2) 
Problems with 
contraceptive method 
1 0.7 (0.3, 1.4) 1.9 (1.0, 3.7) 0.7 (0.4, 1.3) 
Abbreviations; OR: Odds Ratio, CI: Confidence Interval 
* Per one-unit increase in number of children 
 
 
TABLE 4.3 Odds Ratios (95% Confidence Intervals) associated with membership in the 
“Increasing” unmet need trajectory group  (N=850) 
 OR (95% CI) 
Characteristic Consistently Low Increasing Decreasing Consistently High 
Number of living children* 1 1.2 (0.8, 1.9) 0.7 (0.5, 1.0) 2.9 (1.5, 2.6) 
Employed 1 1.1 (0.6, 2.2) 2.1 (1.2, 3.8) 1.2 (0.8, 1.8) 
Main partner desires 
a/another child 
1 1.3 (0.5, 3.4) 2.0 (0.8, 4.9) 0.6 (0.3, 1.0) 
Problems with 
contraceptive method 
1 3.0 (1.4, 6.6) 1.2 (0.5, 2.8) 1.3 (0.7, 2.4) 
Abbreviations; OR: Odds Ratio, CI: Confidence Interval 






TABLE 4.4 Characteristics of women assigned to “Consistently Low,” “Increasing,” “Decreasing,” and “Consistently 










 Median IQR Median IQR Median IQR Median IQR 
Posterior probability of group 
membership 0.95 0.71-0.99 1.00 0.89-0.72 0.99 0.85-1.00 0.90 0.70-0.98 
Age (years) 30.1 27-32 29.8 28-32 30.3 27-33 30.8 27-33 
Income (ZAR) 2000.0 1000-3000 2500.0 1700-4200 2000.0 1005-3200 2000.0 1000-3500 
No. living children 1 0-2 1 0-2 1 0-1 1 1-2 
CD4 count (cells/µl) 314.0 192-474 311.0 172-492 247.5 175-455 319.0 175-454 
Months on ART 13.6 6-26 12.6 6-22 11.3 3-21 13.3 6-26 
 n % n % n % n % 
Lost to follow-up at 6 months 20 9.4 1 1.4 4 3.5 35 7.8 
Became pregnant during follow-
up 35 16.4 6 8.2 17 14.7 91 20.4 
Unmet need at study enrollment 12 5.6 4 5.5 107 92.2 346 77.4 
Planned to conceive next 12 
months 109 50.9 40 54.8 76 65.5 148 33.1 
In relationship with main partner 
≥3 years 108 50.5 50 68.5 68 58.6 290 64.9 
Has living children 158 73.8 52 71.2 77 66.4 379 84.8 
Education completed         
None-Grade 10 58 27.1 17 23.3 33 28.5 110 24.6 
Grade 11-Grade 12 125 58.4 49 67.1 63 54.3 275 61.5 
Post-grad degree or certificate 31 14.5 7 9.6 20 17.2 62 13.9 
Social grant recipient 60 28.0 19 26.0 15 12.9 110 24.6 
Employed 115 53.7 44 60.3 79 68.1 272 60.9 
Disclosed HIV status to main 
partner* 145 83.8 55 75.3 27 75.7 356 82.4 
Any physical IPV with main 




Main partner desires a/another child* 145 67.8 63 86.3 104 89.7 332 74.3 
No 28 16.2 10 13.7 7 6.3 100 23.2 
Yes 131 75.7 59 80.8 92 82.3 287 66.4 
Unsure 14 8.1 4 5.5 12 10.8 45 10.4 
Problems with prior contraceptive method 29 13.6 19 26.0 14 12.1 84 18.8 
Provider discussed future childbearing 89 41.6 33 45.2 45 38.8 178 39.8 
Provider discussed PMTCT 139 65.0 52 71.2 43 62.9 309 69.1 
Provider discussed HC options 101 47.2 40 54.8 38 32.8 231 51.7 
Provider discouraged having a/another child 9 4.2 7 9.6 5 4.3 32 7.2 
Abbreviations; IQR: Interquartile Range, ART: Antiretroviral therapy, No.: Number, IPV: Intimate Partner Violence, HC: Hormonal Contraception, 




















   
TABLE 4.5 Characteristics of recent ART initiators assigned to “Consistently Low,” “Increasing,” “Decreasing,” and 










 Median IQR Median IQR Median IQR Median IQR 
Posterior probability of group 
membership 0.95 0.71-0.99 1.00 0.89-0.72 0.99 0.85-1.00 0.90 0.70-0.98 
Age (years) 28.8 27-31 30.6 25-33 30.3 28-33 30.0 27-32 
Income (ZAR) 1300.00 500-2000 2500.0 850-3500 1800.0 1000-4200 1800.0 1300-3000 
No. living children 0 0-1 1 0-1 1 0-1 1 0-2 
CD4 count (cells/µl) 132.0 71-192 165.0 110-179 151.0 105-186 140.0 68-175 
Months on ART 1.9 1-2 0.7 0-2 0.9 0-2 1.0 0-2 
 n % n % n % n % 
Lost to follow-up at 6 months 4 9.8 1 4.2 1 4.8 7 9.9 
Became pregnant during follow-
up 9 22.0 2 8.3 0 0 14 19.7 
Unmet need at study enrollment 1 2.4 11 45.8 18 85.7 64 90.1 
Planned to conceive next 12 
months 22 53.7 20 83.3 18 85.7 30 42.3 
In relationship with main partner 
≥3 years 8 19.5 14 58.3 13 61.9 44 62.0 
Education completed         
None-Grade 10 15 36.6 8 33.3 7 33.3 26 36.6 
Grade 11-Grade 12 24 58.5 11 45.8 12 57.1 38 53.5 
Post-grad degree or certificate 2 4.9 5 20.8 2 9.5 7 9.9 
Social grant recipient 6 14.6 4 16.7 1 4.8 12 16.9 
Employed 17 41.5 12 50.0 12 57.1 42 59.2 
Disclosed HIV status to main 
partner* 21 84.0 16 69.6 18 85.7 57 87.7 
Any physical IPV with main 





   
Main partner desires a/another child*         
No 2 8.0 0 0 1 4.8 13 20.0 
Yes 22 88.0 21 91.3 18 85.7 44 67.7 
Unsure 1 4.0 2 8.7 2 9.5 8 12.3 
Problems with prior contraceptive method 1 2.4 4 16.7 3 14.3 11 15.5 
Provider discussed future childbearing 18 43.9 8 33.3 7 33.3 35 49.3 
Provider discussed PMTCT 21 51.2 14 58.3 11 52.4 39 54.9 
Provider discussed HC options 12 29.3 10 41.7 6 28.6 26 36.6 
Provider discouraged having a/another child 5 12.2 1 4.2 1 4.8 1 1.4 
Abbreviations; IQR: Interquartile Range, ART: Antiretroviral therapy, No.: Number, IPV: Intimate Partner Violence, HC: Hormonal Contraception, 






















FIGURE 4.1 Predicted trajectories of unmet need for contraception among HIV-infected 
women taking ART in Johannesburg, 2009-2011  
 
Panel A represents predicted trajectories for the four-group quadratic model estimated for the 
full cohort (N=850). Panel B represents predicted trajectories for the four-group cubic model 
estimated for recent initiators of ART (N=157). Dots represent the observed proportion of 
women with unmet need for contraception among those assigned to a given trajectory group on 
the basis of their maximum posterior group membership probability. Curves represent the 
proportion of women with unmet need for contraception as estimated by the model for a given 
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FIGURE 4.2 Fertility intentions and contraceptive use over time, stratified by assigned 
trajectory group based on each participant’s highest posterior group-membership 
probability for the full cohort (N=850) 
 
At each monthly assessment women were either 1) not married, co-habitating, or sexually 
active, 2) trying to conceive, 3) using a reliable method of contraception to prevent pregnancy 
(contraceptive users) and 4) not using a reliable method of contraception to prevent pregnancy 
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FIGURE 4.3 Predicted trajectories of unmet need for contraception using quarterly 
measurements among HIV-infected women taking ART in Johannesburg, 2009-2011.  
Panel A represents predicted trajectories for the four-group cubic model estimated for the full 
cohort (N=850) with unmet need for contraception assessed every three months. Panel B 
represents predicted trajectories for the four-group cubic model estimated for recent initiators of 
ART (N=157) with unmet need for contraception assessed every three months. Dots represent 
the observed proportion of women with unmet need for contraception among those assigned to 
a given trajectory group on the basis of their maximum posterior group membership probability. 
Curves represent the proportion of women with unmet need for contraception as estimated by 
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FIGURE 4.4 Predicted trajectories of unmet need for contraception among non-pregnant 
HIV-infected women taking ART in Johannesburg, 2009-2011.  
Trajectories are presented for the four-group quadratic model estimated for women who did not 
become pregnant during the 12-month follow-up period (N=701). Dots represent the observed 
proportion of women with unmet need for contraception among those assigned to a given 
trajectory group on the basis of their maximum posterior group membership probability. Curves 
represent the proportion of women with unmet need for contraception as estimated by the 
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CHAPTER V: AIM 2 
 
The effect of fertility intentions on attendance at HIV clinical care visits among HIV-infected 
women on antiretroviral therapy in South Africa 
 
1. Introduction 
Nearly 3.4 million people in South Africa are accessing lifesaving antiretroviral therapy 
(ART), making South Africa’s national ART program the largest in the world.36 In 2016, South 
Africa scaled up ART coverage by expanding ART eligibility for all persons living with HIV, 
irrespective of CD4 cell count.122 Through this ambitious universal test and treat (UTT) initiative 
and guided by UNAIDS 90-90-90 targets,123 South Africa aims to significantly reduce HIV-
associated mortality and the number of new infections by 2020. The extent to which South 
Africa can meet these targets will depend on maximizing the proportion of those with HIV who 
sustain virologic suppression through care attendance and treatment adherence in the period 
following diagnosis.   
ART offered through Option B+ has been available in South Africa to all women who are 
pregnant or breastfeeding since early 2015,76 but challenges persist keeping women engaged in 
care during pregnancy and the postpartum period. ART coverage is substantially higher in HIV-
infected women than in men in South Africa,36 but significant concerns around adherence and 
retention have emerged around women who obtain treatment through Option B+.77-79 Several 
studies have reported poor adherence and high rates of loss to follow-up (LTFU) or attrition from 
care among women who initiate ART during pregnancy compared to women who initiate ART 
for their own health,26,27,29 especially in the postpartum period.28,80,81 While factors that cause 




women who initiate ART through PMTCT may be less motivated to remain in care in the 
postpartum period after the risk of mother-to-child transmission has decreased.24,28,82  
One factor that that may influence engagement in care- both in the preconception and 
postpartum periods- is decision making around childbearing. Women who are planning to 
conceive have different clinical needs than those what wish to prevent pregnancy,124 
precipitating potential differences in the frequency with which women attend HIV clinical care 
visits. Concerns about horizontal transmission in the periconception period125,126 or mother-to-
child transmission9 after conception may also motivate women who are planning to conceive to 
have a more consistent relationship with HIV care. Evidence distinguishing different HIV care 
patterns among women trying and not trying to conceive could potentially inform new models for 
care delivery the preconception period. Here, we estimated the effect of fertility intentions on 
attendance at HIV clinical care visits in the preconception period among HIV-infected women on 
ART in Johannesburg, South Africa. 
2. Methods 
2.2 Study Setting, Population and Procedures 
This is a secondary analysis of data from a prospective cohort study conducted in 
Johannesburg between 2009 and 2011 originally designed to estimate the 12-month incidence 
of pregnancy in HIV-infected women on ART. Full study procedures and eligibility criteria have 
been published elsewhere.5,32,33 In brief, all non-pregnant, sexually active women between the 
ages of 18 and 35 were eligible for participation if they had not delivered a pregnancy in the last 
three months; were not breastfeeding, had not had a previous tubal ligation, hysterectomy, or bi-
lateral oophorectomy; and had not been diagnosed as permanently infertile. Pregnancy was 
assessed using urine-based tests administered by study staff (One Step hCG Urine Pregnancy 
Test, Atlas Link Technology, Beijing) and confirmed through repeat testing. After providing 
written informed consent, women meeting eligibility criteria completed an interviewer-




fertility history and intentions, contraceptive use, and sexual risk behaviors. ART regimen 
information, CD4 cell count and viral load data were confirmed through medical record review, 
pharmacy and laboratory records. Follow-up visits coincided with regular clinic visits, every 1-3 
months based on clinic protocol and provincial ART supply. During follow-up visits, women were 
tested for pregnancy and HIV-associated clinical outcomes were updated. Contraceptive use 
and fertility intentions were assessed using a short questionnaire at each follow-up visit. 
2.3 Outcome and Exposure Assessment 
To estimate the effect of fertility intentions on attendance at HIV clinical care visits, we 
constructed an analytic cohort in which each woman was followed from study enrollment 
through the completion of 12 months of follow-up or until date of censoring if she died, became 
pregnant or was known to have transferred to another clinic. We partitioned the 12-month 
follow-up period following enrollment into four discrete three-month intervals (quarters). 
Attendance at HIV clinical care visits was assessed dichotomously in each quarter; a woman 
was flagged as having attended a visit in a given interval if she attended one or more routine 
HIV clinical care visits in that interval (yes/no).  
 Fertility intentions were measured at enrollment using three questions that asked about 
current and future fertility intentions. Women were first asked if they were trying to conceive at 
time of interview (yes/no). Those that said no or were uncertain were then asked if they were 
planning to conceive in the next 12 months (yes/no/uncertain). Those that said no or were 
uncertain were then asked if they were planning to conceive someday in the future 
(yes/no/uncertain). In main analyses, women were then classified as having either current 
fertility intentions (trying at time of interview), short-term fertility intentions (planning to conceive 
in the next 12 months), long-term fertility intentions (planning to conceive in the future), or 
having no plans to conceive. Women who were uncertain about conceiving in the next 12 




intentions and not short-term fertility intentions, and women who were uncertain about their 
long-term fertility intentions were grouped with women with no plans to conceive.  
In additional analyses, we assessed the effect of time-varying fertility intentions on 
attendance at HIV clinical care visits. Women were asked if they were trying to conceive at the 
time of each HIV clinical care visit (yes/no).   
2.4 Statistical Analysis 
Demographic and clinical characteristics of women at enrollment were described overall 
and by dichotomized fertility intentions (any plans to conceive vs. no plans to conceive) using 
proportions for categorical variables and medians for continuous variables. Generalized linear 
models with a logit link were used to estimate the association between each category of fertility 
intentions and attendance, using generalized estimating equations (GEE) with an exchangeable 
correlation structure to account for within-subject correlation (multiple intervals of attendance 
per woman).127  
Multivariable models were used to adjust for covariates identified using causal directed 
acyclic graphs (DAGs). Confounders included for adjustment were measured at enrollment and 
included age, marital status, ART duration, partner fertility intentions, having prior children and 
having a provider that discouraged having a/another child. We opted not to control for 
contraceptive use in multivariable models, since use of hormonal contraception likely mediates 
the causal relationship between fertility intentions and HIV care attendance and adjustment 
might bias estimates of the total effects of the exposures.  
In time-varying analysis, we included a time lag for fertility intentions whereby we 
assessed attendance in each interval among women who reported they were either trying or not 
trying to conceive in the previous interval. Among women who attended more than one clinical 
care visit within a three-month period (and subsequently had more than one assessment of 
fertility intentions in a given interval), we used exposure information from the first visit only. To 




within a three-month period, we initially excluded these women from our analysis (complete 
case analysis). To assess the robustness of our findings, we used inverse probability weighting 
to account for missing exposure data in the full cohort. 
We considered potential effect measure modification (EMM) by ART duration, age and 
CD4 count assessed at enrollment using two dichotomized measures of fertility intentions ((any 
plans to conceive vs. no plans to conceive) and (currently trying to conceive vs. not currently 
trying to conceive)). To assess EMM by ART duration, we compared women who had initiated 
ART within three months of study enrollment (recent initiators)  with those that had been on ART 
for more than three months (ART experienced). Our cutoff of three months was used to 
approximate those who had started ART on or around the time of study entry. Age was 
categorized about the median of 30 years and CD4 count was categorized about of 200 cells/µl. 
To formally test for EMM, we included an interaction term between the dichotomized exposure 
of fertility intentions and each of the proposed modifiers. Interaction terms with Wald test 
statistic p-values of <0.10 were considered significant and stratified estimates were reported. 
We considered both the magnitude and precision of stratum-specific estimates when making a 
final determination of EMM. 
To account for potential exposure misclassification of fertility intentions, we conducted 
additional analyses around women who were uncertain about their fertility intentions in the short 
term and the long term. All analyses were conducted using SAS statistical software (SAS, 
version 9.4, Cary, NC).  
3. Results 
We enrolled 850 women and followed them for 12 months between August, 2009 and March, 
2011. Over the 12-month period, 149 women (17.5%) became pregnant and contributed a 
median of 6.2 months (IQR 4, 9) of follow-up before they were censored. Twenty-eight (3.8%) 
women did not return to care after their initial study visit. Women were approximately 30 years 




80.0%) had previously been pregnant. Median time since HIV diagnosis was 24 months (IQR 
12, 48), and median time since ART initiation was 13 months (IQR 5, 24).  
 Most (742/850, 87.3%) women were planning to conceive at some point; 12.4% 
(105/850) were trying to conceive at enrollment. Compared to women who had no plans to 
conceive, women who were planning to conceive were less likely to have been previously 
pregnant (590/680 (86.8%) vs. 184/184 (100.0%)), to be taking hormonal contraception 
(162/680 (23.8%) vs. 62/184 (36.5%)) and to have been pregnant at HIV diagnosis (197/680 
(29.0%) vs.  74/170 (45.5%)). Women who were trying to conceive had, on average, fewer living 
children (median 1 child (IQR 0,1) vs. median 2 children (IQR 2,3)). HIV-associated outcomes 
were similar in both groups.  
Figure 5.1 illustrates the observed proportion of women attending an HIV clinical care 
visit over 12 months of follow-up. The probability of attending a visit decreased from 93.2% at 
month 3 to 81.0% at month 12. Table 5.2 includes odds ratios (ORs) and adjusted odds ratios 
(aORs) for attendance by each category of fertility intentions. We found no difference in clinic 
attendance by fertility intentions (comparing each category with those that were not trying to 
conceive) in unadjusted and adjusted models (Table 5.2). We similarly found no effect when we 
considered time-varying fertility intentions (Table 5.3). Results for sensitivity analyses where we 
classified women with uncertain fertility intentions as either not trying or trying to conceive in the 
short- and long-term were similar.  
Table 5.4 summarizes the different effect estimates stratified by each potential effect 
measure modifier. There did not appear to be modification by ART duration, age, or CD4 count 
when we compared women who were currently trying to conceive with those who were not 
trying to conceive at enrollment. Stratum specific estimates differed, however, when we 
compared women with any plans for conception with those women who had no plans to 
conceive. Among women who had recently initiated ART, those that planned to conceive were 




plans to conceive; however, precision was limited. Among women with a CD4 count of 200 or 
less, those that planned to conceive were more likely to attend HIV clinical care visits (aOR 
2.31, 95% CI: 1.21, 4.41) than those with no plans to conceive.  
4. Discussion 
In this study of South African HIV-infected women taking ART, we observed a high probability of 
attendance at HIV clinical care visits over a 12-month period. We expected that women with 
plans to conceive in the short term would demonstrate greater engagement in care than those 
not planning a pregnancy.  In fact, we observed comparable engagement overall between these 
groups.  Subgroup analyses suggested that in women who recently initiated ART and among 
those with a low CD4 count at study enrollment, plans for pregnancy were associated with high 
attendance at HIV clinical care visits. To our knowledge, no other studies have previously 
assessed the relationship between fertility intentions and retention in HIV care.  
There are several reasons why women who are planning to become pregnant may have 
a more consistent relationship with HIV clinical care at ART initiation than those with no plans 
for childbearing. In HIV-infected women, maternal concerns around mother-to-child transmission 
are thought to motivate care attendance during pregnancy.9,11,24,28,30 It could be that pregnancy 
planners exhibit similar health-seeking behaviors in the preconception period. Concerns about 
horizontal transmission to HIV-uninfected partners during attempts to become pregnant may 
also prompt better attendance at HIV clinical care visits,125,126 though data included in this 
analysis preempted wide understanding of treatment as prevention.128  
We did not find an association between fertility intentions and care attendance in our full 
cohort, which included women with diverse ART experience at time of study entry. Women who 
are new to care and treatment may have greater HIV treatment optimism than those that are 
ART experienced, which may have motivated more frequent attendance for those with 
childbearing plans.  Additionally, as our study’s origin coincided with study entry and not with 




women who chose to participate must have previously been retained in care up until the point of 
study entry. For example, women who initiated ART >1 year prior to study entry must have 
remained engaged in care up until the start of follow-up to be included in the cohort. Conversely, 
women who initiated ART at study entry did not have the same requirements for retention 
because the start of their follow-up period coincided with their entry into the study. We suspect 
that women in our study with a longer history of ART experience were innately better about 
attending HIV care visits overall, and that effect estimates for the full cohort may have been may 
diluted.108  
Our analyses had several limitations. First, this study covered a 12-month period, which 
precluded us from assessing differences in LTFU or other long-term measures of care 
engagement. Consistent with other reported short-term estimates of retention in South Africa,120 
overall attendance in our study remained high (>80%) at the end of 12 months. This likely 
limited the precision of our effect estimates. Second, measures of fertility intentions included in 
this analysis may not reflect ambivalence around childbearing,131 and women in our study may 
have misreported their plans for pregnancy. A strength of this study, however, was our use of 
prospectively collected measures of fertility intentions that preceded pregnancy, which may 
have reduced potential exposure misclassification.132 Third, we were unable to assess the effect 
of fertility intentions on treatment adherence in our cohort, and while we assume that women 
who frequently attended care were also adherent to their ART, this may not be the case.  
Finally, at the time of study enrollment, non-pregnant women were only eligible for lifelong ART 
initiation with a CD4 count ≤200 cells/μl cells/ml or WHO clinical stage 4 diagnosis, and thus the 
generalizability of our study findings may be limited.133 While we acknowledge this limitation, we 
believe these population-level differences to be incremental. Nevertheless, future research is 





Despite these limitations, our findings suggest that fertility intentions impact care 
attendance in some women, and that novel strategies are needed to keep women without plans 
for conception retained in HIV care. Prioritizing PMTCT in already pregnant women has been 
widely successful in South Africa, reducing transmission during pregnancy to less than 3%.36 As 
we enter a new era of HIV care and treatment, developing alternative models of care delivery 






5. Tables and Figures 
 
TABLE 5.1 Characteristics at enrollment of 850 HIV-infected women taking ART in 
Johannesburg by dichotomized fertility intentions, 2009-2011 
 Overall 
N=850 (100.0%) 
Any plans to 
conceive 
N=680 (80.0%) 
No plans to 
conceive 
N=170 (20.0%) 
 Median IQR Median IQR Median IQR 
Age (years) 30.4 27-33 29.9 27-33 31.8 29-34 
No. living children 1.0 1-2 1.0 0-2 2.0 2-3 
Months since HIV diagnosis 24.0 12-48 24.0 12-48 28.0 12-48 
CD4 count, cells/µl 312.0 178-462 302.0 175-459 345.0 217-468 
HIV Viral load, copies/ml* 49.0 49-58 49.0 49-78 49.0 49-49 
Months on ART 13.2 5-24 13.0 5-24 13.3 6-25 
 n % n % n % 
Employed 510 60.0 402 59.2 108 63.5 
Married/cohabitating  378 44.5 302 44.4 76 44.7 
Ever pregnant 760 89.4 590 86.8 170 100 
Trying to conceive, currently 105 12.4 105 15.4 0 0 
Taking hormonal contraception 224 26.4 162 23.8 62 36.5 
Pregnant at HIV diagnosis 271 31.9 197 29.0 74 45.5 
Recruitment site       
ART initiation site 325 38.2 235 34.6 90 52.9 
ART down-referral site 525 61.8 445 65.4 80 47.1 





TABLE 5.2 Unadjusted and adjusted Odds Ratios for the effect of fertility 
intentions on attendance at HIV clinical care visits 
    Unadjusted  Adjusted* 
  No. (%)  OR (95% CI)  OR (95% CI) 
Categorical Fertility Intentions       
Current Fertility Intentions  170 (12.4)  0.80 (0.45, 1.42)  0.95 (0.51, 1.76) 
Short-Term Fertility 
Intentions 
 291 (34.2)  0.86 (0.54, 1.37)  1.00 (0.61, 1.65) 
Long-Term Fertility 
Intentions 
 284 (33.4)  1.13 (0.70, 1.80)  1.26 (0.77, 2.04) 
No plans to conceive  170 (20.0)  1  1 
 
Abbreviations. No.: Number, OR: Odds Ratio; CI: Confidence Interval 
* Models were adjusted for a minimally sufficient set of confounders including age (≤30, >30), 
marital status (yes/no), time on ART (initiated ART ≤ 3 months, initiated ART >3 months), 
partner fertility intentions (no partner, partner does not desire a/another child, partner unsure, 
partner desires a/another child), any prior living children (yes/no), and provider discouraged 







TABLE 5.3 Unadjusted, adjusted and weighted Odds Ratios for the effect of time-varying 
fertility intentions on attendance at HIV clinical care visits 
    Unadjusted  Adjusted†  Weighted‡ 
  No. (%)*  OR (95% CI)  OR (95% CI)  OR (95% CI) 
Time-varying fertility 
intentions 
        
Trying to 
conceive 
 105 (12.4)  0.89 (0.62, 1.28)  0.94 (0.64, 1.38)  0.89 (0.56, 1.44) 
Not trying to 
conceive 
 745 (87.7)  1  1  1 
Abbreviations. No.: Number, OR: Odds Ratio; CI: Confidence Interval  
* Proportion of those trying and not trying to conceive at enrollment 
† Models were adjusted for a minimally sufficient set of confounders including age (≤30, >30), relationship 
status (yes/no), time on ART (initiated ART ≤3 months, initiated ART >3 months), partner fertility 
intentions (no partner, partner does not desire a/another child, partner unsure, partner desires a/another 
child), any prior living children (yes/no), and provider discouraged future childbearing (yes/no).   
‡ Inverse-probability weighted effect estimates accounted for the following covariates: study 
visit, CD4 count, time on ART (initiated ART ≤3 months, initiated ART >3 months), employment status, 
and social grant status.  
 
 
TABLE 5.4 Adjusted Odds Ratios for attendance at quarterly HIV clinical care visits 




 aOR* (95% CI) 
  Currently Trying to 
Conceive†  
Any Plans to 
Conceive‡ 
Original (dichotomous)    0.94 (0.64, 1.38)  1.09 (0.70, 1.70) 
Modification by ART duration       
Recent initiator  157 (18.5)  0.71 (0.30, 1.69)  2.95 (1.19, 7.30) 
ART experienced  693 (81.5)  0.96 (0.53, 1.76)  0.94 (0.56, 1.60) 
Modification by age       
≤30  523 (61.5)  0.78 (0.41, 1.45)  1.27 (0.74, 2.20) 
>30  327 (38.5)  1.10 (0.50, 2.42)  0.98 (0.41, 2.34) 
Modification by CD4 count       
≤200 cells/µl  405 (47.7)  0.87 (0.41, 1.85)  2.31 (1.21, 4.41) 
>200 cells/µl  445 (52.4)  0.86 (0.46, 1.63)  0.74 (0.41, 1.33) 
Abbreviations. No.: Number, OR: Odds Ratio; CI: Confidence Interval  
* Models were adjusted for a minimally sufficient set of confounders including age (≤30, >30), relationship 
status (yes/no), time on ART (initiated ART ≤ 3 months, initiated ART >3 months), partner fertility 
intentions (no partner, partner does not desire a/another child, partner unsure, partner desires a/another 
child), any prior living children (yes/no), and provider discouraged future childbearing (yes/no).   
† vs. those that were not trying to conceive 



















































1. Summary of Findings 
The overall goal of this research was to better define the family planning needs of HIV-
infected women within the context of HIV clinical care. We conducted our analyses using a rich 
and unique longitudinal cohort of 850 HIV-infected women who were previously on or being 
initiated onto ART in Johannesburg, South Africa.  
In Aim 1, we assessed longitudinal patterns of unmet need for contraception over a 12-
month period using group-based trajectory models. We found that more than 10% of women in 
our full cohort and nearly a quarter of those recently initiating ART were predicted to have 
unmet need that increased over time, indicating they were at higher risk of unintended 
pregnancy as time under observation increased. Our findings indicate that even within a 12-
month period women’s family planning needs may change rapidly, and that a single assessment 
of contraceptive need is insufficient in identifying those at high risk for unintended pregnancy. 
In Aim 2, we estimated the effect of fertility intentions on HIV clinical care visits over a 
12-month period. We found that the overall probability of attending a visit decreased from 93.2% 
at month 3 to 81.0% at month 12. In main analyses, we found no difference in clinic attendance 
by fertility intentions in unadjusted and adjusted models. Among women who had recently 
initiated ART, those that planned to conceive were more likely to attend HIV clinical care visits 
(aOR 2.95, 95% CI: 1.19, 7.30) than those with no plans to conceive; however, precision was 
limited. Among women with a CD4 count of 200 or less, those that planned to conceive were 
more likely to attend HIV clinical care visits (aOR 2.31, 95% CI: 1.21, 4.41) than those with no 




promote engagement in HIV care for women who are not planning to become pregnant in the 
immediate period following ART initiation. 
2. Contributions 
Results from this study provide much-needed insights into the sexual and reproductive 
health of HIV-infected women taking ART in South Africa. To our knowledge, our study is the 
first to show that among HIV-infected women, trajectories of unmet need are dynamic –
potentially increasing or decreasing – over a 12-month period. However, in current clinical 
practice, fertility intentions and contraceptive use are infrequently assessed in the context of HIV 
care. Consequently, women with unmet need for contraception may not be appropriately 
identified as being “at risk” for unintended pregnancy. Notably, among women in our study who 
were predicted to have an increasing probability of unmet need for contraception, only 6% were 
screened has having unmet need for contraception at enrollment. Without intervention, it’s likely 
that these women went on to experience an unintended pregnancy.  
While current national service delivery guidelines promote the integration of sexual and 
reproductive health services with HIV prevention, care and treatment in South Africa,40 
implementation of these guidelines in clinical practice has been limited.41,37 Routine HIV clinical 
care visits represent a potential opportunity to regularly screen for family planning needs, 
particularly among women who do not realize they are able conceive after experiencing sub-
fertility related to HIV-associated disease progression.64-66 Furthermore, regularly assessing the 
family planning needs of women who have trouble achieving viral suppression is critical for both 
prevention of horizontal transmission to HIV-uninfected partners and PMTCT. Our findings 
further suggest that programs that include comprehensive screening for fertility intentions (for 
women and their partners), increase awareness about contraceptive side effects and method 
options, and provide high-quality training on contraceptive methods and safer conception will be 




 Our study has also contributed to an understanding of how childbearing decisions affect 
a woman’s relationship with HIV care. To our knowledge, no other studies have previously 
assessed the relationship between fertility intentions and retention in HIV care outside of the 
pregnancy period. While we did not detect an association between fertility intentions and 
attendance in the full cohort, we found that positive fertility intentions were associated with high 
attendance at HIV clinical care visits among women that had recently initiated ART.  
Our findings have practical implications for HIV care delivery. For women with plans to 
conceive, our results demonstrate that HIV clinical care visits are an optimal space within which 
to offer safer conception services. We strongly advocate that comprehensive screening for 
fertility intentions- for both women and their partners- be prioritized to expand uptake of safer 
conception in this population. Sub-optimal attendance at HIV clinical care visits among women 
without plans to conceive is particularly troubling, as many women in this region often conjointly 
access contraception through HIV care and treatment. Our findings suggest that new models of 
care delivery that target women who wish to prevent or delay childbearing are urgently needed 
to simultaneously improve engagement in care and reduce the burden of unintended 
pregnancies in this population.  
3. Limitations 
Our study was not without several limitations. First, unmet need for contraception is 
derived from measures of fertility intentions and contraceptive use that are subject to potential 
outcome misclassification consistent with data collected by self-report. Self-reported 
contraception use may be subject to social desirability bias,134 and binary measures of fertility 
intentions may be ambiguous and fail to capture ambivalence about conception and future 
pregnancy status.135,136 Because all analyses for Aim 1 were predictive and are without a 
defined causal question, we anticipate that potential misclassification of unmet need for 
contraception did not bias the interpretation of our findings. A strength of this study, however, 




which may have reduced potential exposure misclassification.132 For Aim 2, our findings were 
robust to different exposure classifications of fertility intentions that accounted for potential 
uncertainty around childbearing. Nevertheless, as these analyses were causal, we acknowledge 
potential exposure misclassification as a limitation of this analysis.   
Second, as identified by our DAG, pregnancy is a causal intermediate on the pathway 
between fertility intentions and retention in care for Aim 2. This relationship likely manifests 
because of maternal concerns regarding fetal health and mother-to-child transmission, and 
because women may first present to care after receiving a positive HIV diagnosis through 
antenatal testing. While we anticipate a woman’s relationship with care changes after she 
becomes pregnant, our interest in this study lied more in estimating the total effect of fertility 
intentions prior to pregnancy on retention in care.  
Third, at study entry, eligible women were either on or being initiated onto ART, and 
subsequently differences in developmental trajectories for unmet need may differ by time-on-
ART. Our investigation primarily focused on characterizing trajectories of unmet need for 
contraception in a real-world population of HIV-infected women engaged in HIV care, and our 
study design is indicative of the reality in which women are seen and counseled on 
contraception in the context of HIV clinical care. When we restricted analyses to those women 
that had recently initiated ART, however, trajectories were generally similar to those that 
emerged in the full cohort. 
Fourth, as our study’s origin coincided with study entry and not with another biologically 
meaningful origin (e.g., HIV diagnosis, linked to care, ART initiation),130 women who chose to 
participate must have previously been retained in care up until the point of study entry. For 
example, women who initiated ART >1 year prior to study entry must have remained engaged in 
care up until the start of follow-up to be included in the cohort. Conversely, women who initiated 
ART at study entry did not have the same requirements for retention because the start of their 




with a longer history of ART experience were innately better about attending HIV care visits 
overall, and that effect estimates for the full cohort may have been may diluted.108  
Fifth, study visits during the 12-month follow-up period occurred during clinic visits every 
1-3 months based on clinic protocol and provincial ART supply, and we saw some differences in 
the number and frequency of study visits across participants. However, our selected analytic 
approaches for both Aim 1 and Aim 2 accommodated differences in both the total number of 
observations the frequency of observations. For Aim 1, we repeated our analysis using 
quarterly assessments of unmet need for contraception (vs. monthly) to account for differences 
in study visits. For Aim 2, attendance at HIV clinical care visits was similarly measured every 
three months.  
Finally, at the time of study enrollment, non-pregnant women were only eligible for 
lifelong ART initiation with a CD4 count ≤200 cells/μl cells/ml or WHO clinical stage 4 diagnosis, 
and thus the generalizability of our study findings may be limited. In Aim 1, trajectories of unmet 
need and predictors thereof may differ in the current era of expanded HIV care and treatment. 
However, we believe any differences to be incremental, as we saw little difference in CD4 count 
by trajectory group. Furthermore, trajectories were largely similar among recent ART initiators 
who started treatment for their own health. In Aim 2, women who initiate ART because of 
disease severity may be more likely to be retained in care compared to women who initiate ART 
during pregnancy. While we acknowledge these limitations to our analyses, we believe these 
population-level differences to be incremental overall. Notably, a recent study found that despite 
revised thresholds for ART initiation in sub-Saharan Africa, CD4 counts at presentation to care 
have not changed over the past ten years.137 Thus, despite expanded availability of ART 
through UTT, we believe our study findings are generalizable to the current population of HIV-







Through this research we have provided a more nuanced understanding of the family 
planning needs of HIV-infected women. We have demonstrated that changing fertility intentions 
and contraceptive use inform dynamic patterns of unmet need for contraception over a 12-
month period, and that women without plans for pregnancy may have a measurably 
inconsistently relationship with HIV care in the period following ART initiation. Our findings 
suggest that routine and comprehensive screening for fertility intentions within HIV clinical care 
visits is integral for prevention of unintended pregnancies in this population. As we enter a new 
era of HIV care and treatment, developing alternative models of care delivery that consider the 







APPENDIX 1. Supplementary Group-Based Trajectory Models for Fertility Intentions 
 
 
Figure 1.1. Panel A represents predicted trajectories for the three-group cubic model estimated 
for the full cohort (N=850). Panel B represents predicted trajectories for the three-group 
quadratic model estimated for recent initiators of ART (N=157). Dots represent the observed 
proportion of women trying to conceive among those assigned to a given trajectory group on the 
basis of their maximum posterior group membership probability. Curves represent the 
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APPENDIX 2. Supplementary Analysis of Unmet Need for Contraception 
 
 
Figure 2.1. Panel A represents predicted probability of having unmet need for contraception in 
the full cohort (N=850) over the study period; dashed lines represent upper and lower 95% 
confidence intervals. Panel B represents predicted probability of having unmet need for 
contraception in recent initiators (N=157). Log-binomial models were fit using generalized 
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